Arzneimittelausschreibung 2026_vergebene Aufträge

At a glance

IKK classic is procuring Pharmaceutical products (CPV 33600000). It is divided into 257 lots and has been awarded. Procedure type: Open.

From the notice

Abschluss von Rabattverträgen nach § 130a Abs. 8 SGB V mit einer regulären Laufzeit von 2 Jahren. Vertragsbeginn ist der 01.01.2027. Die Verträge zu den Fachlosen mit der Losnummer 005, 011, 016, 031, 034, 040, 042, 065, 083, 090, 096, 098, 107, 110, 119, 122, 129, 139, 142, 144, 150, 152, 162, 173, 177, 180, 202, 204, 208, 216, 236 und 237 beginnen abweichend von dem regulären Vertragsbeginn (1. Januar 2027) bereits ab dem 01.10.2026. Die Laufzeit der Verträge zu diesen Fachlosen beträgt damit 27 Monate. Die Ausschreibung erfolgt wirkstoffbezogen für die aufgeführten Wirkstoffe und Wirkstoffkombinationen, aufgeteilt in 257 Fachlose. Angebote können ausschließlich nur für verschreibungspflichtige Arzneimittel abgegeben werden. Ausnahmen sind die Fachlose mit der Losnummer 097 (WNK 04 bis 09) und 146 (WNK 04 und 05), in denen jeweils ausschließlich nicht-verschreibungspflichtige, apothekenpflichtige Arzneimittel angeboten werden dürfen. Pro Fachlos wird eine Rabattvereinbarung mit maximal einem, zwei oder drei pharmazeutischen Unternehmern (Bieter oder Bietergemeinschaft) geschlossen (zur Höchstzahl siehe Informationen zum jeweiligen Fachlos).

Key facts

Each fact is from the official notice, last checked 9 November 2026, 20:30 (UTC+01:00).

Status

AwardedOfficial notice · checked 9 Nov 2026, 20:30 (UTC+01:00)

Deadline

No deadline in the noticeOfficial notice · checked 9 Nov 2026, 20:30 (UTC+01:00)

Buyer

IKK classic, Dresden, DEOfficial notice · checked 9 Nov 2026, 20:30 (UTC+01:00)

Main CPV

Pharmaceutical products (CPV 33600000)Official notice · checked 9 Nov 2026, 20:30 (UTC+01:00)

Procedure

OpenOfficial notice · checked 9 Nov 2026, 20:30 (UTC+01:00)

Lots

257Official notice · checked 9 Nov 2026, 20:30 (UTC+01:00)

First published

27 July 2026, 15:42 (UTC+02:00)Official notice · checked 9 Nov 2026, 20:30 (UTC+01:00)

Last published

29 July 2026, 16:25 (UTC+02:00)Official notice · checked 9 Nov 2026, 20:30 (UTC+01:00)

Lots (257)

1. Lot LOT-0001: 001 | Acetylsalicylsäure magensaftresistente Tabletten u.w. [3] [H]

   ATC-Code: B01AC06; Acetylsalicylsäure Darreichungsform(en): Granulat; Kautabletten; magensaftresistente Tabletten; Tabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 3

   CPV

   Pharmaceutical products (CPV 33600000)

   Published value

   €662,842 excl. VAT

2. Lot LOT-0002: 002 | Agomelatin Filmtabletten [3]

   ATC-Code: N06AX22; Agomelatin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

   CPV

   Pharmaceutical products (CPV 33600000)

   Published value

   €489,005 excl. VAT

3. Lot LOT-0003: 003 | Alendronsäure Tabletten u.w. [2]

   ATC-Code: M05BA04; Alendronsäure Darreichungsform(en): Brausetabletten; Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2

   CPV

   Pharmaceutical products (CPV 33600000)

   Published value

   €847,633 excl. VAT

4. Lot LOT-0004: 004 | Allopurinol Tabletten [3]

   ATC-Code: M04AA01; Allopurinol Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3

   CPV

   Pharmaceutical products (CPV 33600000)

   Published value

   €950,165 excl. VAT

5. Lot LOT-0005: 005 | Amifampridin Tabletten [1]

   ATC-Code: N07XX05; Amifampridin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1

   CPV

   Pharmaceutical products (CPV 33600000)

   Published value

   €427,767 excl. VAT

6. Lot LOT-0006: 006 | Amisulprid Filmtabletten [2]

   ATC-Code: N05AL05; Amisulprid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

   CPV

   Pharmaceutical products (CPV 33600000)

   Published value

   €272,927 excl. VAT

7. Lot LOT-0007: 007 | Amisulprid Tabletten [3]

   ATC-Code: N05AL05; Amisulprid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3

   CPV

   Pharmaceutical products (CPV 33600000)

   Published value

   €443,988 excl. VAT

8. Lot LOT-0008: 008 | Amitriptylin Filmtabletten u.w. [2]

   ATC-Code: N06AA09; Amitriptylin Darreichungsform(en): Filmtabletten; Tabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 2

   CPV

   Pharmaceutical products (CPV 33600000)

   Published value

   €689,008 excl. VAT

9. Lot LOT-0009: 009 | Amlodipin Tabletten [3]

   ATC-Code: C08CA01; Amlodipin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3

   CPV

   Pharmaceutical products (CPV 33600000)

   Published value

   €1,652,640 excl. VAT

10. Lot LOT-0010: 010 | Anagrelid Hartkapseln [2]

    ATC-Code: L01XX35; Anagrelid Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €455,487 excl. VAT

11. Lot LOT-0011: 011 | Apremilast Filmtabletten [3]

    ATC-Code: L04AA32; Apremilast Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €866,300 excl. VAT

12. Lot LOT-0012: 012 | Aprepitant Hartkapseln [2]

    ATC-Code: A04AD12; Aprepitant Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €138,588 excl. VAT

13. Lot LOT-0013: 013 | Atenolol Filmtabletten u.w. [2]

    ATC-Code: C07AB03; Atenolol Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €68,962 excl. VAT

14. Lot LOT-0014: 014 | Atomoxetin Hartkapseln [3]

    ATC-Code: N06BA09; Atomoxetin Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €421,487 excl. VAT

15. Lot LOT-0015: 015 | Atorvastatin + Ezetimib Filmtabletten u.w. [2]

    ATC-Code: C10BA05; Atorvastatin + Ezetimib Darreichungsform(en): Filmtabletten; Hartkapseln; Tabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €2,722,952 excl. VAT

16. Lot LOT-0016: 016 | Atovaquon Suspension zum Einnehmen [1]

    ATC-Code: P01AX06; Atovaquon Darreichungsform(en): Suspension zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €98,025 excl. VAT

17. Lot LOT-0017: 017 | Azathioprin Filmtabletten u.w. [2]

    ATC-Code: L04AX01; Azathioprin Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €617,329 excl. VAT

18. Lot LOT-0018: 018 | Azelastin + Fluticason Nasenspray [1]

    ATC-Code: R01AD58; Azelastin + Fluticason Darreichungsform(en): Nasenspray Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €240,653 excl. VAT

19. Lot LOT-0019: 019 | Betamethason + Salicylsäure Salbe [1]

    ATC-Code: D07XC01; Betamethason + Salicylsäure Darreichungsform(en): Salbe Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €156,449 excl. VAT

20. Lot LOT-0020: 020 | Betamethason Creme [1]

    ATC-Code: D07AC01; Betamethason Darreichungsform(en): Creme Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €211,504 excl. VAT

21. Lot LOT-0021: 021 | Betamethason Emulsion [1]

    ATC-Code: D07AC01; Betamethason Darreichungsform(en): Emulsion Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €136,912 excl. VAT

22. Lot LOT-0022: 022 | Betamethason Lösung [1]

    ATC-Code: D07AC01; Betamethason Darreichungsform(en): Lösung Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €127,669 excl. VAT

23. Lot LOT-0023: 023 | Betamethason Salbe [1]

    ATC-Code: D07AC01; Betamethason Darreichungsform(en): Salbe Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €58,660 excl. VAT

24. Lot LOT-0024: 024 | Bicalutamid Filmtabletten [2]

    ATC-Code: L02BB03; Bicalutamid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €384,408 excl. VAT

25. Lot LOT-0025: 025 | Bimatoprost + Timolol EDO [2]

    ATC-Code: S01ED51; Bimatoprost + Timolol Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €413,198 excl. VAT

26. Lot LOT-0026: 026 | Bimatoprost EDO [1]

    ATC-Code: S01EE03; Bimatoprost Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €288,667 excl. VAT

27. Lot LOT-0027: 027 | Bisoprolol + Hydrochlorothiazid Filmtabletten [2]

    ATC-Code: C07BB07; Bisoprolol + Hydrochlorothiazid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €321,627 excl. VAT

28. Lot LOT-0028: 028 | Bisoprolol Filmtabletten u.w. [3]

    ATC-Code: C07AB07; Bisoprolol Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €2,507,223 excl. VAT

29. Lot LOT-0029: 029 | Bosentan Filmtabletten [2]

    ATC-Code: C02KX01; Bosentan Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €1,697,386 excl. VAT

30. Lot LOT-0030: 030 | Brinzolamid Augentropfen [2]

    ATC-Code: S01EC04; Brinzolamid Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €607,346 excl. VAT

31. Lot LOT-0031: 031 | Budesonid Hartkapseln mit veränderter Wirkstofffreisetzung [1]

    ATC-Code: A07EA06; Budesonid Darreichungsform(en): Hartkapseln mit veränderter Wirkstofffreisetzung Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €298,162 excl. VAT

32. Lot LOT-0032: 032 | Budesonid Suspension für einen Vernebler [2]

    ATC-Code: R03BA02; Budesonid Darreichungsform(en): Suspension für einen Vernebler Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €495,424 excl. VAT

33. Lot LOT-0033: 033 | Buprenorphin + Naloxon Sublingualtabletten [1]

    ATC-Code: N07BC51; Buprenorphin + Naloxon Darreichungsform(en): Sublingualtabletten Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €34,183 excl. VAT

34. Lot LOT-0034: 034 | Buprenorphin Pflaster transdermal Tragedauer 3 Tage [1] [H]

    ATC-Code: N02AE01; Buprenorphin Darreichungsform(en): Pflaster transdermal Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €138,811 excl. VAT

35. Lot LOT-0035: 035 | Bupropion Tabletten mit veränderter Wirkstofffreisetzung [3]

    ATC-Code: N06AX12; Bupropion Darreichungsform(en): Tabletten mit veränderter Wirkstofffreisetzung Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €2,520,709 excl. VAT

36. Lot LOT-0036: 036 | Cabergolin Tabletten [1]

    ATC-Code: G02CB03; Cabergolin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €147,740 excl. VAT

37. Lot LOT-0037: 037 | Candesartan + Amlodipin Tabletten u.w. [2]

    ATC-Code: C09DB07; Candesartan + Amlodipin Darreichungsform(en): Hartkapseln; Tabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €2,038,709 excl. VAT

38. Lot LOT-0038: 038 | Candesartan + Hydrochlorothiazid Tabletten [3]

    ATC-Code: C09DA06; Candesartan + Hydrochlorothiazid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €2,484,538 excl. VAT

39. Lot LOT-0039: 039 | Candesartan Tabletten [3]

    ATC-Code: C09CA06; Candesartan Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €10,344,179 excl. VAT

40. Lot LOT-0040: 040 | Carglumsäure Tabletten zur Herstellung ei. Suspension z. Einnehmen [1]

    ATC-Code: A16AA05; Carglumsäure Darreichungsform(en): Tablette zur Herstellung einer Suspension zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €1,415,752 excl. VAT

41. Lot LOT-0041: 041 | Carvedilol Tabletten u.w. [3]

    ATC-Code: C07AG02; Carvedilol Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €657,846 excl. VAT

42. Lot LOT-0042: 042 | Chinin Filmtabletten [1]

    ATC-Code: P01BC01; Chinin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €804,717 excl. VAT

43. Lot LOT-0043: 043 | Chlormadinon + Ethinylestradiol Filmtabletten [2] [H]

    ATC-Code: G03AA15; Chlormadinon + Ethinylestradiol Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €61,190 excl. VAT

44. Lot LOT-0044: 044 | Citalopram Filmtabletten [3]

    ATC-Code: N06AB04; Citalopram Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €781,122 excl. VAT

45. Lot LOT-0045: 045 | Clopidogrel Filmtabletten [2]

    ATC-Code: B01AC04; Clopidogrel Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €1,208,950 excl. VAT

46. Lot LOT-0046: 046 | Clozapin Tabletten [2]

    ATC-Code: N05AH02; Clozapin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €898,442 excl. VAT

47. Lot LOT-0047: 047 | Colecalciferol + Fluorid-Ion Tabletten [1] [H]

    ATC-Code: A11CC55; Colecalciferol + Fluorid-Ion Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €71,764 excl. VAT

48. Lot LOT-0048: 048 | Colecalciferol Tropfen zum Einnehmen [1]

    ATC-Code: A11CC05; Colecalciferol Darreichungsform(en): Tropfen zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €94,877 excl. VAT

49. Lot LOT-0049: 049 | Colestyramin Pulver zur Herstellung einer Suspension zum Einnehmen u.w. [1]

    ATC-Code: C10AC01; Colestyramin Darreichungsform(en): Granulat zur Herstellung einer Suspension zum Einnehmen; Pulver zur Herstellung einer Suspension zum Einnehmen; Pulver Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €278,904 excl. VAT

50. Lot LOT-0050: 050 | Cyanocobalamin Filmtabletten u.w. [1] [H]

    ATC-Code: B03BA01; Cyanocobalamin Darreichungsform(en): Filmtabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €206,196 excl. VAT

51. Lot LOT-0051: 051 | Cyproteron + Ethinylestradiol überzogene Tabletten u.w. [1]

    ATC-Code: G03HB01; Cyproteron + Estrogen Darreichungsform(en): Filmtabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €24,569 excl. VAT

52. Lot LOT-0052: 052 | Dabigatran Hartkapseln [2]

    ATC-Code: B01AE07; Dabigatran Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €921,005 excl. VAT

53. Lot LOT-0053: 053 | Darunavir Filmtabletten [2]

    ATC-Code: J05AE10; Darunavir Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €366,029 excl. VAT

54. Lot LOT-0054: 054 | Dasatinib Filmtabletten [3]

    ATC-Code: L01EA02; Dasatinib Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €1,311,167 excl. VAT

55. Lot LOT-0055: 055 | Desmopressin Tabletten [1]

    ATC-Code: H01BA02; Desmopressin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €591,888 excl. VAT

56. Lot LOT-0056: 056 | Diclofenac Augentropfen [1]

    ATC-Code: S01BC03; Diclofenac Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €36,558 excl. VAT

57. Lot LOT-0057: 057 | Diclofenac Gel AK [1] [H]

    ATC-Code: D11AX18; Diclofenac Darreichungsform(en): Gel Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €1,064,137 excl. VAT

58. Lot LOT-0058: 058 | Diclofenac Tabletten magensaftresistent u.w. [2]

    ATC-Code: M01AB05; Diclofenac Darreichungsform(en): Filmtabletten; Hartkapseln; Hartkapseln mit veränderter Wirkstofffreisetzung; magensaftresistente Hartkapseln; magensaftresistente Tabletten; Tabletten zur Herstellung einer Suspension zum Einnehmen; überzogene Tabletten; Weichkapseln Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €68,370 excl. VAT

59. Lot LOT-0059: 059 | Dienogest + Estradiol valerat Tabletten u.w. [2]

    ATC-Code: G03FA15; Dienogest + Estradiol valerat Darreichungsform(en): Filmtabletten; Tabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €212,378 excl. VAT

60. Lot LOT-0060: 060 | Donepezil Filmtabletten u.w. [2]

    ATC-Code: N06DA02; Donepezil Darreichungsform(en): Filmtabletten; Schmelztabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €572,176 excl. VAT

61. Lot LOT-0061: 061 | Doxazosin Retardtabletten [2]

    ATC-Code: C02CA04; Doxazosin Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €204,369 excl. VAT

62. Lot LOT-0062: 062 | Doxazosin Tabletten [2] [H]

    ATC-Code: C02CA04; Doxazosin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €595,598 excl. VAT

63. Lot LOT-0063: 063 | Doxepin Filmtabletten u.w. [3]

    ATC-Code: N06AA12; Doxepin Darreichungsform(en): Filmtabletten; Hartkapseln; Tabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €302,485 excl. VAT

64. Lot LOT-0064: 064 | Dutasterid Weichkapseln [1]

    ATC-Code: G04CB02; Dutasterid Darreichungsform(en): Weichkapseln Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €89,581 excl. VAT

65. Lot LOT-0065: 065 | Eltrombopag Filmtabletten [3] [H]

    ATC-Code: B02BX05; Eltrombopag Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €899,552 excl. VAT

66. Lot LOT-0066: 066 | Emtricitabin, Tenofovir + Efavirenz Filmtabletten [2]

    ATC-Code: J05AR06; Emtricitabin, Tenofovirdisoproxil + Efavirenz Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €512,606 excl. VAT

67. Lot LOT-0067: 067 | Enalapril + Hydrochlorothiazid Tabletten [2]

    ATC-Code: C09BA02; Enalapril + Hydrochlorothiazid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €190,024 excl. VAT

68. Lot LOT-0068: 068 | Enalapril + Lercanidipin Filmtabletten [2]

    ATC-Code: C09BB02; Enalapril + Lercanidipin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €497,502 excl. VAT

69. Lot LOT-0069: 069 | Enoxaparin Injektionslösung in einer Fertigspritze [2]

    ATC-Code: B01AB05; Enoxaparin Darreichungsform(en): Injektionslösung in einer Fertigspritze Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €5,397,408 excl. VAT

70. Lot LOT-0070: 070 | Entacapon Filmtabletten [1]

    ATC-Code: N04BX02; Entacapon Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €39,122 excl. VAT

71. Lot LOT-0071: 071 | Entecavir Filmtabletten [2]

    ATC-Code: J05AF10; Entecavir Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €298,737 excl. VAT

72. Lot LOT-0072: 072 | Erlotinib Filmtabletten [1]

    ATC-Code: L01EB02; Erlotinib Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €37,223 excl. VAT

73. Lot LOT-0073: 073 | Eslicarbazepin Tabletten [3]

    ATC-Code: N03AF04; Eslicarbazepin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €254,039 excl. VAT

74. Lot LOT-0074: 074 | Ethosuximid Weichkapseln [2]

    ATC-Code: N03AD01; Ethosuximid Darreichungsform(en): Weichkapseln Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €102,983 excl. VAT

75. Lot LOT-0075: 075 | Etoricoxib Filmtabletten [3]

    ATC-Code: M01AH05; Etoricoxib Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €1,962,275 excl. VAT

76. Lot LOT-0076: 076 | Everolimus Tabletten [2] [H]

    ATC-Code: L01EG02; Everolimus Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €270,507 excl. VAT

77. Lot LOT-0077: 077 | Exemestan Filmtabletten u.w. [3]

    ATC-Code: L02BG06; Exemestan Darreichungsform(en): Filmtabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €258,507 excl. VAT

78. Lot LOT-0078: 078 | Fampridin Retardtabletten [3]

    ATC-Code: N07XX07; Fampridin Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €1,444,578 excl. VAT

79. Lot LOT-0079: 079 | Febuxostat Filmtabletten [3]

    ATC-Code: M04AA03; Febuxostat Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €332,751 excl. VAT

80. Lot LOT-0080: 080 | Felodipin Retardtabletten [2]

    ATC-Code: C08CA02; Felodipin Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €254,081 excl. VAT

81. Lot LOT-0081: 081 | Fentanyl Lutschtabletten [1]

    ATC-Code: N02AB03; Fentanyl Darreichungsform(en): Lutschtabletten Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €48,375 excl. VAT

82. Lot LOT-0082: 082 | Fentanyl Pflaster transdermal I [2]

    ATC-Code: N02AB03; Fentanyl Darreichungsform(en): Pflaster transdermal Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €822,136 excl. VAT

83. Lot LOT-0083: 083 | Fentanyl Pflaster transdermal II [1]

    ATC-Code: N02AB03; Fentanyl Darreichungsform(en): Pflaster transdermal Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €40,508 excl. VAT

84. Lot LOT-0084: 084 | Fentanyl Sublingualtabletten [1]

    ATC-Code: N02AB03; Fentanyl Darreichungsform(en): Sublingualtabletten Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €757,139 excl. VAT

85. Lot LOT-0085: 085 | Fexofenadin Filmtabletten [2]

    ATC-Code: R06AX26; Fexofenadin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €385,841 excl. VAT

86. Lot LOT-0086: 086 | Finasterid Filmtabletten [3]

    ATC-Code: G04CB01; Finasterid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €639,231 excl. VAT

87. Lot LOT-0087: 087 | Fluconazol Hartkapseln u.w. [2]

    ATC-Code: J02AC01; Fluconazol Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €744,475 excl. VAT

88. Lot LOT-0088: 088 | Fluorouracil + Salicylsäure Lösung [1]

    ATC-Code: L01BC52; Fluorouracil + Salicylsäure Darreichungsform(en): Lösung Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €195,347 excl. VAT

89. Lot LOT-0089: 089 | Fluoxetin Tabletten u.w. [3]

    ATC-Code: N06AB03; Fluoxetin Darreichungsform(en): Filmtabletten; Hartkapseln; Tabletten; Tabletten zur Herstellung einer Suspension zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €486,208 excl. VAT

90. Lot LOT-0090: 090 | Formoterol + Beclomethason Dosieraerosol [3]

    ATC-Code: R03AK08; Formoterol + Beclomethason Darreichungsform(en): Dosieraerosol Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €10,205,410 excl. VAT

91. Lot LOT-0091: 091 | Fosaprepitant Pulver zur Herstellung einer Infusionslösung [1]

    ATC-Code: A04AD12; Fosaprepitant Darreichungsform(en): Pulver zur Herstellung einer Infusionslösung Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €317,262 excl. VAT

92. Lot LOT-0092: 092 | Fulvestrant Injektionslösung in einer Fertigspritze u.w. [3]

    ATC-Code: L02BA03; Fulvestrant Darreichungsform(en): Injektionslösung; Injektionslösung in einer Fertigspritze Anzahl der vorgesehenen Vertragspartner: 3

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €493,124 excl. VAT

93. Lot LOT-0093: 093 | Furosemid Tabletten [2]

    ATC-Code: C03CA01; Furosemid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €234,536 excl. VAT

94. Lot LOT-0094: 094 | Galantamin Retardkapseln [2]

    ATC-Code: N06DA04; Galantamin Darreichungsform(en): Retardkapseln Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €52,700 excl. VAT

95. Lot LOT-0095: 095 | Glimepirid Tabletten [2]

    ATC-Code: A10BB12; Glimepirid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €259,427 excl. VAT

96. Lot LOT-0096: 096 | Guanfacin Retardtabletten [1]

    ATC-Code: C02AC02; Guanfacin Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €1,292,206 excl. VAT

97. Lot LOT-0097: 097 | Hydrocortison Creme [1] [H]

    ATC-Code: D07AA02; Hydrocortison Darreichungsform(en): Creme Anzahl der vorgesehenen Vertragspartner: 1

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €39,124 excl. VAT

98. Lot LOT-0098: 098 | Hydrocortison Tabletten [2]

    ATC-Code: H02AB09; Hydrocortison Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €557,745 excl. VAT

99. Lot LOT-0099: 099 | Hydromorphon Hartkapseln [2]

    ATC-Code: N02AA03; Hydromorphon Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2

    CPV

    Pharmaceutical products (CPV 33600000)

    Published value

    €1,306,758 excl. VAT

100. Lot LOT-0100: 100 | Hydroxycarbamid Hartkapseln [2]

     ATC-Code: L01XX05; Hydroxycarbamid Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €340,103 excl. VAT

101. Lot LOT-0101: 101 | Hydroxyzin Filmtabletten [1]

     ATC-Code: N05BB01; Hydroxyzin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €26,220 excl. VAT

102. Lot LOT-0102: 102 | Ibandronsäure Filmtabletten [1]

     ATC-Code: M05BA06; Ibandronsäure Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €129,389 excl. VAT

103. Lot LOT-0103: 103 | Ibandronsäure Infusionslösungskonzentrat [1]

     ATC-Code: M05BA06; Ibandronsäure Darreichungsform(en): Infusionslösungskonzentrat Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €105,572 excl. VAT

104. Lot LOT-0104: 104 | Ibandronsäure Injektionslösung [2]

     ATC-Code: M05BA06; Ibandronsäure Darreichungsform(en): Injektionslösung Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €322,663 excl. VAT

105. Lot LOT-0105: 105 | Ibuprofen Filmtabletten u.w. [2]

     ATC-Code: M01AE01; Ibuprofen Darreichungsform(en): Filmtabletten; Kautabletten; Tabletten; Weichgelatinekapseln; Kapseln; überzogene Tabletten; Schmelztabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €3,283,399 excl. VAT

106. Lot LOT-0106: 106 | Imiquimod Creme [1]

     ATC-Code: D06BB10; Imiquimod Darreichungsform(en): Creme Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €365,756 excl. VAT

107. Lot LOT-0107: 107 | Ipratropiumbromid Dosieraerosol [1]

     ATC-Code: R03BB01; Ipratropiumbromid Darreichungsform(en): Dosieraerosol Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €84,168 excl. VAT

108. Lot LOT-0108: 108 | Irbesartan + Hydrochlorothiazid Filmtabletten [3]

     ATC-Code: C09DA04; Irbesartan + Hydrochlorothiazid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €153,411 excl. VAT

109. Lot LOT-0109: 109 | Ketorolac Augentropfen [1]

     ATC-Code: S01BC05; Ketorolac Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €39,175 excl. VAT

110. Lot LOT-0110: 110 | Lactulose Sirup [2] [H]

     ATC-Code: A06AD11; Lactulose Darreichungsform(en): Sirup Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €208,050 excl. VAT

111. Lot LOT-0111: 111 | Lansoprazol magensaftresistente Hartkapseln u.w. [2]

     ATC-Code: A02BC03; Lansoprazol Darreichungsform(en): Magensaftresistente Hartkapseln; Kapseln magensaftresistent Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €75,247 excl. VAT

112. Lot LOT-0112: 112 | Lanthan(III)-carbonat Kautabletten [1]

     ATC-Code: V03AE03; Lanthan(III)-carbonat Darreichungsform(en): Kautabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €551,748 excl. VAT

113. Lot LOT-0113: 113 | Latanoprost Augentropfen [2]

     ATC-Code: S01EE01; Latanoprost Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,212,252 excl. VAT

114. Lot LOT-0114: 114 | Latanoprost Einzeldosispipetten [1]

     ATC-Code: S01EE01; Latanoprost Darreichungsform(en): Einzeldosispipetten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,272,238 excl. VAT

115. Lot LOT-0115: 115 | Leflunomid Filmtabletten u.w. [2]

     ATC-Code: L04AK01; Leflunomid Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,431,277 excl. VAT

116. Lot LOT-0116: 116 | Lenalidomid Hartkapseln [3]

     ATC-Code: L04AX04; Lenalidomid Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €398,282 excl. VAT

117. Lot LOT-0117: 117 | Letrozol Filmtabletten [3]

     ATC-Code: L02BG04; Letrozol Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €654,598 excl. VAT

118. Lot LOT-0118: 118 | Levetiracetam Filmtabletten [3]

     ATC-Code: N03AX14; Levetiracetam Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €2,352,368 excl. VAT

119. Lot LOT-0119: 119 | Levetiracetam Granulat [1]

     ATC-Code: N03AX14; Levetiracetam Darreichungsform(en): Granulat Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €47,340 excl. VAT

120. Lot LOT-0120: 120 | Levetiracetam Infusionslösungskonzentrat [1]

     ATC-Code: N03AX14; Levetiracetam Darreichungsform(en): Infusionslösungskonzentrat Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €34,605 excl. VAT

121. Lot LOT-0121: 121 | Levodopa + Benserazid Retardkapseln [1]

     ATC-Code: N04BA02; Levodopa + Benserazid Darreichungsform(en): Retardkapseln Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €797,847 excl. VAT

122. Lot LOT-0122: 122 | Levodopa + Carbidopa Retardtabletten [2]

     ATC-Code: N04BA02; Levodopa + Carbidopa Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €281,402 excl. VAT

123. Lot LOT-0123: 123 | Levonorgestrel + Ethinylestradiol Filmtabletten [2]

     ATC-Code: G03AA07; Levonorgestrel + Ethinylestradiol Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €323,662 excl. VAT

124. Lot LOT-0124: 124 | Levonorgestrel + Ethinylestradiol überzogene Tabletten [2]

     ATC-Code: G03AA07; Levonorgestrel + Ethinylestradiol Darreichungsform(en): Überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €141,550 excl. VAT

125. Lot LOT-0125: 125 | Lisdexamfetamin Hartkapseln [2]

     ATC-Code: N06BA12; Lisdexamfetamin Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €3,777,219 excl. VAT

126. Lot LOT-0126: 126 | Lisinopril + Hydrochlorothiazid Tabletten [2]

     ATC-Code: C09BA03; Lisinopril + Hydrochlorothiazid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €189,292 excl. VAT

127. Lot LOT-0127: 127 | Lisinopril Tabletten [2]

     ATC-Code: C09AA03; Lisinopril Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €233,342 excl. VAT

128. Lot LOT-0128: 128 | Lorazepam Tabletten u.w. [2]

     ATC-Code: N05BA06; Lorazepam Darreichungsform(en): Lyophilisat zum Einnehmen; Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €285,774 excl. VAT

129. Lot LOT-0129: 129 | Mebeverin Retardkapseln u.w. [1]

     ATC-Code: A03AA04; Mebeverin Darreichungsform(en): Hartkapseln, retardiert; Hartkapseln mit veränderter Wirkstofffreisetzung; Retardkapseln Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €110,008 excl. VAT

130. Lot LOT-0130: 130 | Mesalazin Suppositorien [2]

     ATC-Code: A07EC02; Mesalazin Darreichungsform(en): Suppositorien Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €759,356 excl. VAT

131. Lot LOT-0131: 131 | Mesalazin Tabletten magensaftresistent [1]

     ATC-Code: A07EC02; Mesalazin Darreichungsform(en): Tabletten magensaftresistent Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €781,708 excl. VAT

132. Lot LOT-0132: 132 | Metamizol natrium Tabletten u.w. [2]

     ATC-Code: N02BB02; Metamizol-Natrium Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €4,776,515 excl. VAT

133. Lot LOT-0133: 133 | Metamizol natrium Tropfen zum Einnehmen u.w. [2]

     ATC-Code: N02BB02; Metamizol-Natrium Darreichungsform(en): Tropfen zum Einnehmen; Lösung; Tropfen Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,412,194 excl. VAT

134. Lot LOT-0134: 134 | Metformin Filmtabletten [3]

     ATC-Code: A10BA02; Metformin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €3,356,442 excl. VAT

135. Lot LOT-0135: 135 | Methocarbamol Filmtabletten u.w. [2]

     ATC-Code: M03BA03; Methocarbamol Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €2,001,479 excl. VAT

136. Lot LOT-0136: 136 | Methylphenidat Hartkapseln mit veränderter Wirkstofffreisetzung [1] [H]

     ATC-Code: N06BA04; Methylphenidat Darreichungsform(en): Hartkapseln mit veränderter Wirkstofffreisetzung Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €146,102 excl. VAT

137. Lot LOT-0137: 137 | Methylphenidat Retardtabletten [2]

     ATC-Code: N06BA04; Methylphenidat Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,008,468 excl. VAT

138. Lot LOT-0138: 138 | Metoprolol succinat Retardtabletten [2]

     ATC-Code: C07AB02; Metoprolol Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €3,618,070 excl. VAT

139. Lot LOT-0139: 139 | Metoprolol tartrat Retardtabletten mit ZOK-Kinetik [2] [H]

     ATC-Code: C07AB02; Metoprolol Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €124,929 excl. VAT

140. Lot LOT-0140: 140 | Metoprolol tartrat Retardtabletten ohne ZOK-Kinetik [2]

     ATC-Code: C07AB02; Metoprolol Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €176,572 excl. VAT

141. Lot LOT-0141: 141 | Metoprolol tartrat Tabletten [2]

     ATC-Code: C07AB02; Metoprolol Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €197,032 excl. VAT

142. Lot LOT-0142: 142 | Midazolam Injektionslösung u.w. [1]

     ATC-Code: N05CD08; Midazolam Darreichungsform(en): Injektionslösung; Infusionslösung; Injektions-/Infusionslösung; Ampullen Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €72,539 excl. VAT

143. Lot LOT-0143: 143 | Milnacipran Hartkapseln [1]

     ATC-Code: N06AX17; Milnacipran Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €75,406 excl. VAT

144. Lot LOT-0144: 144 | Minoxidil Tabletten [2]

     ATC-Code: C02DC01; Minoxidil Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €665,363 excl. VAT

145. Lot LOT-0145: 145 | Mirtazapin Filmtabletten u.w. [3]

     ATC-Code: N06AX11; Mirtazapin Darreichungsform(en): Filmtabletten; Schmelztabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €2,300,359 excl. VAT

146. Lot LOT-0146: 146 | Mometason Nasenspray u.w. [2] [H]

     ATC-Code: R01AD09; Mometason Darreichungsform(en): Nasenspray; Suspension; Nasendosierspray Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €632,835 excl. VAT

147. Lot LOT-0147: 147 | Morphin sulfat Filmtabletten u.w. [1]

     ATC-Code: N02AA01; Morphin Darreichungsform(en): Filmtabletten; Hartkapseln Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €268,296 excl. VAT

148. Lot LOT-0148: 148 | Moxonidin Filmtabletten [2]

     ATC-Code: C02AC05; Moxonidin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,651,900 excl. VAT

149. Lot LOT-0149: 149 | Multienzyme magensaftresistente Hartkapseln u.w. [2] [H]

     ATC-Code: A09AA02; Triacylglycerollipase Darreichungsform(en): Magensaftresistente, polydisperse Mikrotabletten in Kapseln; Magensaftresistente, polydisperse Pellets in Beuteln; Magensaftresistente, polydisperse Pellets in Kapseln; Magensaftresistentes, polydisperses Granulat in Beuteln; magensaftresistente Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €5,555,630 excl. VAT

150. Lot LOT-0150: 150 | Naproxen + Esomeprazol Tabletten mit veränderter Wirkstofffreisetzung [1]

     ATC-Code: M01AE52; Naproxen + Esomeprazol Darreichungsform(en): Tablette mit veränderter Wirkstofffreisetzung Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €249,070 excl. VAT

151. Lot LOT-0151: 151 | Naratriptan Filmtabletten [2]

     ATC-Code: N02CC02; Naratriptan Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €151,549 excl. VAT

152. Lot LOT-0152: 152 | Nilotinib Hartkapseln [2]

     ATC-Code: L01EA03; Nilotinib Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €4,150,194 excl. VAT

153. Lot LOT-0153: 153 | Nitisinon Hartkapseln [1]

     ATC-Code: A16AX04; Nitisinon Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €705,270 excl. VAT

154. Lot LOT-0154: 154 | Olanzapin Filmtabletten u.w. [3]

     ATC-Code: N05AH03; Olanzapin Darreichungsform(en): Filmtabletten; Schmelztabletten; Tabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,867,997 excl. VAT

155. Lot LOT-0155: 155 | Olmesartan, Amlodipin + Hydrochlorothiazid Filmtabletten [3]

     ATC-Code: C09DX03; Olmesartan medoxomil, Amlodipin + Hydrochlorothiazid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €720,240 excl. VAT

156. Lot LOT-0156: 156 | Omeprazol magensaftresistente Hartkapseln u.w. [3]

     ATC-Code: A02BC01; Omeprazol Darreichungsform(en): magensaftresistente Hartkapseln; magensaftresistente Tabletten; Kapseln magensaftresistent Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,845,574 excl. VAT

157. Lot LOT-0157: 157 | Oxycodon + Naloxon Retardtabletten [3]

     ATC-Code: N02AA55; Oxycodon + Naloxon Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €2,210,072 excl. VAT

158. Lot LOT-0158: 158 | Paliperidon Depot-Injektionssuspension [2] [H]

     ATC-Code: N05AX13; Paliperidon Darreichungsform(en): Depot-Injektionssuspension Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €3,225,518 excl. VAT

159. Lot LOT-0159: 159 | Pantoprazol Tabletten magensaftresistent [3]

     ATC-Code: A02BC02; Pantoprazol Darreichungsform(en): Tabletten magensaftresistent Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €6,996,120 excl. VAT

160. Lot LOT-0160: 160 | Paricalcitol Injektionslösung [1]

     ATC-Code: H05BX02; Paricalcitol Darreichungsform(en): Injektionslösung Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €492,749 excl. VAT

161. Lot LOT-0161: 161 | Paricalcitol Weichkapseln [1]

     ATC-Code: H05BX02; Paricalcitol Darreichungsform(en): Weichkapseln Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €124,833 excl. VAT

162. Lot LOT-0162: 162 | Pazopanib Filmtabletten [2]

     ATC-Code: L01EX03; Pazopanib Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €678,198 excl. VAT

163. Lot LOT-0163: 163 | Perindopril arginin + Indapamid Filmtabletten u.w. [1]

     ATC-Code: C09BA04; Perindopril + Indapamid Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €734,047 excl. VAT

164. Lot LOT-0164: 164 | Pipamperon Lösung zum Einnehmen [1]

     ATC-Code: N05AD05; Pipamperon Darreichungsform(en): Lösung zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €338,879 excl. VAT

165. Lot LOT-0165: 165 | Pipamperon Tabletten [1]

     ATC-Code: N05AD05; Pipamperon Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €821,472 excl. VAT

166. Lot LOT-0166: 166 | Pomalidomid Hartkapseln [2]

     ATC-Code: L04AX06; Pomalidomid Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,511,318 excl. VAT

167. Lot LOT-0167: 167 | Pramipexol Retardtabletten [3]

     ATC-Code: N04BC05; Pramipexol Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,039,128 excl. VAT

168. Lot LOT-0168: 168 | Prasugrel Filmtabletten [2]

     ATC-Code: B01AC22; Prasugrel Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €810,767 excl. VAT

169. Lot LOT-0169: 169 | Pravastatin Tabletten u.w. [2]

     ATC-Code: C10AA03; Pravastatin Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €178,302 excl. VAT

170. Lot LOT-0170: 170 | Prednisolon Tabletten [3]

     ATC-Code: H02AB06; Prednisolon Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,097,973 excl. VAT

171. Lot LOT-0171: 171 | Pregabalin Hartkapseln u.w. [3]

     ATC-Code: N02BF02; Pregabalin Darreichungsform(en): Hartkapseln; Tabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €5,119,295 excl. VAT

172. Lot LOT-0172: 172 | Pregabalin Lösung zum Einnehmen [1]

     ATC-Code: N02BF02; Pregabalin Darreichungsform(en): Lösung zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €58,138 excl. VAT

173. Lot LOT-0173: 173 | Pridinol Tabletten [1]

     ATC-Code: M03BX03; Pridinol Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €2,076,211 excl. VAT

174. Lot LOT-0174: 174 | Promethazin Filmtabletten u.w. [1]

     ATC-Code: R06AD02; Promethazin Darreichungsform(en): Filmtabletten; überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €143,243 excl. VAT

175. Lot LOT-0175: 175 | Prucaloprid Filmtabletten [2]

     ATC-Code: A06AX05; Prucaloprid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €483,328 excl. VAT

176. Lot LOT-0176: 176 | Pyridostigmin Retardtabletten [1]

     ATC-Code: N07AA02; Pyridostigmin Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €430,301 excl. VAT

177. Lot LOT-0177: 177 | Pyridostigmin überzogene Tabletten u.w. [1]

     ATC-Code: N07AA02; Pyridostigmin Darreichungsform(en): überzogene Tabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €110,282 excl. VAT

178. Lot LOT-0178: 178 | Quetiapin Filmtabletten [3]

     ATC-Code: N05AH04; Quetiapin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €2,028,562 excl. VAT

179. Lot LOT-0179: 179 | Quetiapin Retardtabletten [3]

     ATC-Code: N05AH04; Quetiapin Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €599,172 excl. VAT

180. Lot LOT-0180: 180 | Raltegravir Filmtabletten [1]

     ATC-Code: J05AJ01; Raltegravir Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €185,453 excl. VAT

181. Lot LOT-0181: 181 | Ramipril + Hydrochlorothiazid Tabletten [2]

     ATC-Code: C09BA05; Ramipril + Hydrochlorothiazid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,364,230 excl. VAT

182. Lot LOT-0182: 182 | Ramipril Tabletten [3]

     ATC-Code: C09AA05; Ramipril Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €3,036,130 excl. VAT

183. Lot LOT-0183: 183 | Rasagilin Tabletten [3]

     ATC-Code: N04BD02; Rasagilin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €200,985 excl. VAT

184. Lot LOT-0184: 184 | Repaglinid Tabletten [2]

     ATC-Code: A10BX02; Repaglinid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €62,403 excl. VAT

185. Lot LOT-0185: 185 | Risperidon Filmtabletten [3]

     ATC-Code: N05AX08; Risperidon Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €595,421 excl. VAT

186. Lot LOT-0186: 186 | Risperidon Lösung zum Einnehmen [1]

     ATC-Code: N05AX08; Risperidon Darreichungsform(en): Lösung zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €34,505 excl. VAT

187. Lot LOT-0187: 187 | Rivastigmin Hartkapseln [2]

     ATC-Code: N06DA03; Rivastigmin Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €435,668 excl. VAT

188. Lot LOT-0188: 188 | Rivastigmin Pflaster transdermal [3]

     ATC-Code: N06DA03; Rivastigmin Darreichungsform(en): Pflaster transdermal Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €880,509 excl. VAT

189. Lot LOT-0189: 189 | Rizatriptan Schmelztabletten [2]

     ATC-Code: N02CC04; Rizatriptan Darreichungsform(en): Schmelztabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €296,232 excl. VAT

190. Lot LOT-0190: 190 | Rizatriptan Tabletten [2]

     ATC-Code: N02CC04; Rizatriptan Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €137,311 excl. VAT

191. Lot LOT-0191: 191 | Ropinirol Retardtabletten [3]

     ATC-Code: N04BC04; Ropinirol Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €320,471 excl. VAT

192. Lot LOT-0192: 192 | Rosuvastatin + Ezetimib Filmtabletten u.w. [2]

     ATC-Code: C10BA06; Rosuvastatin + Ezetimib Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €2,991,042 excl. VAT

193. Lot LOT-0193: 193 | Rosuvastatin Filmtabletten [3]

     ATC-Code: C10AA07; Rosuvastatin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €3,070,443 excl. VAT

194. Lot LOT-0194: 194 | Rupatadin Tabletten [1]

     ATC-Code: R06AX28; Rupatadin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €165,748 excl. VAT

195. Lot LOT-0195: 195 | Sertralin Filmtabletten [3]

     ATC-Code: N06AB06; Sertralin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €2,286,901 excl. VAT

196. Lot LOT-0196: 196 | Sevelamer carbonat Pulver zur Herstellung einer Suspension zum Einnehmen [1]

     ATC-Code: V03AE02; Sevelamer Darreichungsform(en): Pulver zur Herstellung einer Suspension zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €82,968 excl. VAT

197. Lot LOT-0197: 197 | Simvastatin Filmtabletten [2]

     ATC-Code: C10AA01; Simvastatin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,826,458 excl. VAT

198. Lot LOT-0198: 198 | Sitagliptin + Metformin Filmtabletten [3]

     ATC-Code: A10BD07; Sitagliptin + Metformin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €2,970,173 excl. VAT

199. Lot LOT-0199: 199 | Sitagliptin Filmtabletten [2]

     ATC-Code: A10BH01; Sitagliptin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,867,063 excl. VAT

200. Lot LOT-0200: 200 | Solifenacin Filmtabletten [3]

     ATC-Code: G04BD08; Solifenacin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €440,164 excl. VAT

201. Lot LOT-0201: 201 | Spironolacton Tabletten u.w. [2]

     ATC-Code: C03DA01; Spironolacton Darreichungsform(en): überzogene Tabletten; Filmtabletten; Kapseln; Tabletten; Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,390,691 excl. VAT

202. Lot LOT-0202: 202 | Sultiam Filmtabletten [1]

     ATC-Code: N03AX03; Sultiam Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €211,582 excl. VAT

203. Lot LOT-0203: 203 | Sumatriptan Filmtabletten u.w. [3]

     ATC-Code: N02CC01; Sumatriptan Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €683,621 excl. VAT

204. Lot LOT-0204: 204 | Tacrolimus Salbe [1]

     ATC-Code: D11AH01; Tacrolimus Darreichungsform(en): Salbe Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €602,452 excl. VAT

205. Lot LOT-0205: 205 | Tadalafil Filmtabletten BPH [3] [H]

     ATC-Code: G04BE08; Tadalafil Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €190,879 excl. VAT

206. Lot LOT-0206: 206 | Tadalafil Filmtabletten PAH [3] [H]

     ATC-Code: G04BE08; Tadalafil Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €958,035 excl. VAT

207. Lot LOT-0207: 207 | Tamsulosin Hartkapseln mit veränderter Wirkstofffreisetzung u.w. [2]

     ATC-Code: G04CA02; Tamsulosin Darreichungsform(en): Hartkapseln mit veränderter Wirkstofffreisetzung; Hartkapseln, retardiert; Retardtabletten; Retardkapseln; Retard-überzogene Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,630,126 excl. VAT

208. Lot LOT-0208: 208 | Tapentadol Filmtabletten [1]

     ATC-Code: N02AX06; Tapentadol Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €740,191 excl. VAT

209. Lot LOT-0209: 209 | Telmisartan + Amlodipin Tabletten [1]

     ATC-Code: C09DB04; Telmisartan + Amlodipin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €113,901 excl. VAT

210. Lot LOT-0210: 210 | Telmisartan + Hydrochlorothiazid Tabletten u.w. [3]

     ATC-Code: C09DA07; Telmisartan + Hydrochlorothiazid Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €275,970 excl. VAT

211. Lot LOT-0211: 211 | Telmisartan Tabletten u.w. [3]

     ATC-Code: C09CA07; Telmisartan Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €542,090 excl. VAT

212. Lot LOT-0212: 212 | Temozolomid Hartkapseln [3]

     ATC-Code: L01AX03; Temozolomid Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,555,527 excl. VAT

213. Lot LOT-0213: 213 | Tenofovir + Emtricitabin Filmtabletten [2]

     ATC-Code: J05AR03; Tenofovirdisoproxil + Emtricitabin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €615,386 excl. VAT

214. Lot LOT-0214: 214 | Tenofovir Filmtabletten [2]

     ATC-Code: J05AF07; Tenofovirdisoproxil Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €568,583 excl. VAT

215. Lot LOT-0215: 215 | Teriflunomid Filmtabletten [3]

     ATC-Code: L04AK02; Teriflunomid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €477,632 excl. VAT

216. Lot LOT-0216: 216 | Testosteron Gel [1]

     ATC-Code: G03BA03; Testosteron Darreichungsform(en): Gel Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €180,092 excl. VAT

217. Lot LOT-0217: 217 | Testosteron Injektionslösung [2]

     ATC-Code: G03BA03; Testosteron Darreichungsform(en): Injektionslösung Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,509,826 excl. VAT

218. Lot LOT-0218: 218 | Tetrabenazin Tabletten [2]

     ATC-Code: N07XX06; Tetrabenazin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €146,321 excl. VAT

219. Lot LOT-0219: 219 | Thiamazol Tabletten u.w. [1]

     ATC-Code: H03BB02; Thiamazol Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €99,755 excl. VAT

220. Lot LOT-0220: 220 | Timolol + Brinzolamid Augentropfen [1]

     ATC-Code: S01ED51; Timolol + Brinzolamid Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €296,946 excl. VAT

221. Lot LOT-0221: 221 | Timolol + Dorzolamid Augentropfen [2]

     ATC-Code: S01ED51; Timolol + Dorzolamid Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,055,436 excl. VAT

222. Lot LOT-0222: 222 | Timolol + Latanoprost Augentropfen [2]

     ATC-Code: S01ED51; Timolol + Latanoprost Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €707,327 excl. VAT

223. Lot LOT-0223: 223 | Timolol + Travoprost Augentropfen [2]

     ATC-Code: S01ED51; Timolol + Travoprost Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €151,468 excl. VAT

224. Lot LOT-0224: 224 | Timolol Augentropfen [1]

     ATC-Code: S01ED01; Timolol Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €183,567 excl. VAT

225. Lot LOT-0225: 225 | Tizanidin Tabletten [1]

     ATC-Code: M03BX02; Tizanidin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €124,471 excl. VAT

226. Lot LOT-0226: 226 | Tolperison Filmtabletten [2]

     ATC-Code: M03BX04; Tolperison Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €205,975 excl. VAT

227. Lot LOT-0227: 227 | Tolvaptan Tabletten ADPKD [1] [H]

     ATC-Code: C03XA01; Tolvaptan Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,552,713 excl. VAT

228. Lot LOT-0228: 228 | Tolvaptan Tabletten SIADH [2] [H]

     ATC-Code: C03XA01; Tolvaptan Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €2,113,932 excl. VAT

229. Lot LOT-0229: 229 | Torasemid Tabletten [2]

     ATC-Code: C03CA04; Torasemid Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €3,629,564 excl. VAT

230. Lot LOT-0230: 230 | Tramadol Hartkapseln u.w. [1]

     ATC-Code: N02AX02; Tramadol Darreichungsform(en): Hartkapseln; Tabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €55,302 excl. VAT

231. Lot LOT-0231: 231 | Tramadol Lösung zum Einnehmen u.w. [3]

     ATC-Code: N02AX02; Tramadol Darreichungsform(en): Lösung zum Einnehmen; Tropfen zum Einnehmen; Lösung; Pumplösung Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €170,478 excl. VAT

232. Lot LOT-0232: 232 | Tramadol Retardtabletten u.w. (2x täglich) [2] [H]

     ATC-Code: N02AX02; Tramadol Darreichungsform(en): Hartkapseln, retardiert; Retardtabletten; Retardkapseln; (Applikationshäufigkeit 2 x täglich) Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €901,208 excl. VAT

233. Lot LOT-0233: 233 | Tranexamsäure Filmtabletten [1]

     ATC-Code: B02AA02; Tranexamsäure Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €67,850 excl. VAT

234. Lot LOT-0234: 234 | Travoprost Augentropfen [2]

     ATC-Code: S01EE04; Travoprost Darreichungsform(en): Augentropfen Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €96,291 excl. VAT

235. Lot LOT-0235: 235 | Trazodon Tabletten [2]

     ATC-Code: N06AX05; Trazodon Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €492,818 excl. VAT

236. Lot LOT-0236: 236 | Treprostinil Infusionslösung [1]

     ATC-Code: B01AC21; Treprostinil Darreichungsform(en): Infusionslösung Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €2,653,133 excl. VAT

237. Lot LOT-0237: 237 | Triamteren + Hydrochlorothiazid Filmtabletten u.w. [1]

     ATC-Code: C03EA01; Triamteren + Hydrochlorothiazid Darreichungsform(en): Filmtabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €38,162 excl. VAT

238. Lot LOT-0238: 238 | Urapidil Retardkapseln [2]

     ATC-Code: C02CA06; Urapidil Darreichungsform(en): Retardkapseln Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,709,665 excl. VAT

239. Lot LOT-0239: 239 | Valaciclovir Filmtabletten [1]

     ATC-Code: J05AB11; Valaciclovir Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €65,567 excl. VAT

240. Lot LOT-0240: 240 | Valganciclovir Filmtabletten [2]

     ATC-Code: J05AB14; Valganciclovir Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €463,249 excl. VAT

241. Lot LOT-0241: 241 | Valproinsäure Lösung zum Einnehmen [1]

     ATC-Code: N03AG01; Valproinsäure Darreichungsform(en): Lösung zum Einnehmen Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €232,954 excl. VAT

242. Lot LOT-0242: 242 | Valsartan + Amlodipin Filmtabletten [3]

     ATC-Code: C09DB01; Valsartan + Amlodipin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,693,403 excl. VAT

243. Lot LOT-0243: 243 | Valsartan + Hydrochlorothiazid Filmtabletten [3]

     ATC-Code: C09DA03; Valsartan + Hydrochlorothiazid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €815,592 excl. VAT

244. Lot LOT-0244: 244 | Valsartan Filmtabletten [3]

     ATC-Code: C09CA03; Valsartan Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,677,567 excl. VAT

245. Lot LOT-0245: 245 | Valsartan, Amlodipin + Hydrochlorothiazid Filmtabletten [2]

     ATC-Code: C09DX01; Valsartan, Amlodipin + Hydrochlorothiazid Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €1,648,563 excl. VAT

246. Lot LOT-0246: 246 | Venlafaxin Retardkapseln u.w. [3]

     ATC-Code: N06AX16; Venlafaxin Darreichungsform(en): Hartkapseln, retardiert; Retardtabletten; Hartkapseln mit veränderter Wirkstofffreisetzung; Retardkapseln Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €2,033,334 excl. VAT

247. Lot LOT-0247: 247 | Venlafaxin Tabletten [2]

     ATC-Code: N06AX16; Venlafaxin Darreichungsform(en): Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €130,251 excl. VAT

248. Lot LOT-0248: 248 | Verapamil Filmtabletten [2]

     ATC-Code: C08DA01; Verapamil Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €120,872 excl. VAT

249. Lot LOT-0249: 249 | Verapamil Retardtabletten [2]

     ATC-Code: C08DA01; Verapamil Darreichungsform(en): Retardtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €227,918 excl. VAT

250. Lot LOT-0250: 250 | Vinorelbin Weichkapseln [1]

     ATC-Code: L01CA04; Vinorelbin Darreichungsform(en): Weichkapseln Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €191,721 excl. VAT

251. Lot LOT-0251: 251 | Zidovudin + Lamivudin Filmtabletten [1]

     ATC-Code: J05AR01; Zidovudin + Lamivudin Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €61,023 excl. VAT

252. Lot LOT-0252: 252 | Zoledronsäure Infusionslösung 5mg [1]

     ATC-Code: M05BA08; Zoledronsäure Darreichungsform(en): Infusionslösung Anzahl der vorgesehenen Vertragspartner: 1

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €192,504 excl. VAT

253. Lot LOT-0253: 253 | Zoledronsäure Infusionslösungskonzentrat [2]

     ATC-Code: M05BA08; Zoledronsäure Darreichungsform(en): Infusionslösungskonzentrat Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €195,844 excl. VAT

254. Lot LOT-0254: 254 | Zolmitriptan Schmelztabletten u.w. [2]

     ATC-Code: N02CC03; Zolmitriptan Darreichungsform(en): Filmtabletten; Schmelztabletten; Tabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €121,433 excl. VAT

255. Lot LOT-0255: 255 | Zolpidem Filmtabletten [2]

     ATC-Code: N05CF02; Zolpidem Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €150,324 excl. VAT

256. Lot LOT-0256: 256 | Zonisamid Hartkapseln [2]

     ATC-Code: N03AX15; Zonisamid Darreichungsform(en): Hartkapseln Anzahl der vorgesehenen Vertragspartner: 2

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €435,063 excl. VAT

257. Lot LOT-0257: 257 | Zopiclon Filmtabletten [3]

     ATC-Code: N05CF01; Zopiclon Darreichungsform(en): Filmtabletten Anzahl der vorgesehenen Vertragspartner: 3

     CPV

     Pharmaceutical products (CPV 33600000)

     Published value

     €422,086 excl. VAT

Timeline

1. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €662,842 excl. VAT; Tenders received: 5; Lot LOT-0001.
2. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €662,842 excl. VAT; Tenders received: 5; Lot LOT-0001.
3. 8 July 2026: Award. Winner: Dexcel Pharma GmbH; Award value: €662,842 excl. VAT; Tenders received: 5; Lot LOT-0001.
4. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €662,842 excl. VAT; Tenders received: 5; Lot LOT-0001.
5. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €662,842 excl. VAT; Tenders received: 5; Lot LOT-0001.
6. 8 July 2026: Award. Winner: Dexcel Pharma GmbH; Award value: €662,842 excl. VAT; Tenders received: 5; Lot LOT-0001.
7. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €489,005 excl. VAT; Tenders received: 4; Lot LOT-0002.
8. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €489,005 excl. VAT; Tenders received: 4; Lot LOT-0002.
9. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €489,005 excl. VAT; Tenders received: 4; Lot LOT-0002.
10. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €489,005 excl. VAT; Tenders received: 4; Lot LOT-0002.
11. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €489,005 excl. VAT; Tenders received: 4; Lot LOT-0002.
12. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €489,005 excl. VAT; Tenders received: 4; Lot LOT-0002.
13. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €847,633 excl. VAT; Tenders received: 7; Lot LOT-0003.
14. 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €847,633 excl. VAT; Tenders received: 7; Lot LOT-0003.
15. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €847,633 excl. VAT; Tenders received: 7; Lot LOT-0003.
16. 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €847,633 excl. VAT; Tenders received: 7; Lot LOT-0003.
17. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €950,165 excl. VAT; Tenders received: 4; Lot LOT-0004.
18. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €950,165 excl. VAT; Tenders received: 4; Lot LOT-0004.
19. 8 July 2026: Award. Winner: HEC Pharm GmbH; Award value: €950,165 excl. VAT; Tenders received: 4; Lot LOT-0004.
20. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €950,165 excl. VAT; Tenders received: 4; Lot LOT-0004.
21. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €950,165 excl. VAT; Tenders received: 4; Lot LOT-0004.
22. 8 July 2026: Award. Winner: HEC Pharm GmbH; Award value: €950,165 excl. VAT; Tenders received: 4; Lot LOT-0004.
23. 8 July 2026: Award. Winner: Hormosan Pharma GmbH; Award value: €427,767 excl. VAT; Tenders received: 3; Lot LOT-0005.
24. 8 July 2026: Award. Winner: Hormosan Pharma GmbH; Award value: €427,767 excl. VAT; Tenders received: 3; Lot LOT-0005.
25. 8 July 2026: Award. Winner: Holsten Pharma GmbH; Award value: €272,927 excl. VAT; Tenders received: 5; Lot LOT-0006.
26. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €272,927 excl. VAT; Tenders received: 5; Lot LOT-0006.
27. 8 July 2026: Award. Winner: Holsten Pharma GmbH; Award value: €272,927 excl. VAT; Tenders received: 5; Lot LOT-0006.
28. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €272,927 excl. VAT; Tenders received: 5; Lot LOT-0006.
29. 8 July 2026: Award. Winner: Holsten Pharma GmbH; Award value: €443,988 excl. VAT; Tenders received: 5; Lot LOT-0007.
30. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €443,988 excl. VAT; Tenders received: 5; Lot LOT-0007.
31. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €443,988 excl. VAT; Tenders received: 5; Lot LOT-0007.
32. 8 July 2026: Award. Winner: Holsten Pharma GmbH; Award value: €443,988 excl. VAT; Tenders received: 5; Lot LOT-0007.
33. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €443,988 excl. VAT; Tenders received: 5; Lot LOT-0007.
34. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €443,988 excl. VAT; Tenders received: 5; Lot LOT-0007.
35. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €689,008 excl. VAT; Tenders received: 3; Lot LOT-0008.
36. 8 July 2026: Award. Winner: BG Neuraxpharm / Hexal GbR (H e x a l Aktiengesellschaft, neuraxpharm Arzneimittel GmbH); Award value: €689,008 excl. VAT; Tenders received: 3; Lot LOT-0008.
37. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €689,008 excl. VAT; Tenders received: 3; Lot LOT-0008.
38. 8 July 2026: Award. Winner: BG Neuraxpharm / Hexal GbR (H e x a l Aktiengesellschaft, neuraxpharm Arzneimittel GmbH); Award value: €689,008 excl. VAT; Tenders received: 3; Lot LOT-0008.
39. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,652,640 excl. VAT; Tenders received: 3; Lot LOT-0009.
40. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,652,640 excl. VAT; Tenders received: 3; Lot LOT-0009.
41. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,652,640 excl. VAT; Tenders received: 3; Lot LOT-0009.
42. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,652,640 excl. VAT; Tenders received: 3; Lot LOT-0009.
43. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,652,640 excl. VAT; Tenders received: 3; Lot LOT-0009.
44. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,652,640 excl. VAT; Tenders received: 3; Lot LOT-0009.
45. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €455,487 excl. VAT; Tenders received: 7; Lot LOT-0010.
46. 8 July 2026: Award. Winner: HIKMA PHARMA GMBH; Award value: €455,487 excl. VAT; Tenders received: 7; Lot LOT-0010.
47. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €455,487 excl. VAT; Tenders received: 7; Lot LOT-0010.
48. 8 July 2026: Award. Winner: HIKMA PHARMA GMBH; Award value: €455,487 excl. VAT; Tenders received: 7; Lot LOT-0010.
49. 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €866,300 excl. VAT; Tenders received: 13; Lot LOT-0011.
50. 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €866,300 excl. VAT; Tenders received: 13; Lot LOT-0011.
51. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €866,300 excl. VAT; Tenders received: 13; Lot LOT-0011.
52. 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €866,300 excl. VAT; Tenders received: 13; Lot LOT-0011.
53. 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €866,300 excl. VAT; Tenders received: 13; Lot LOT-0011.
54. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €866,300 excl. VAT; Tenders received: 13; Lot LOT-0011.
55. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €138,588 excl. VAT; Tenders received: 3; Lot LOT-0012.
56. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €138,588 excl. VAT; Tenders received: 3; Lot LOT-0012.
57. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €138,588 excl. VAT; Tenders received: 3; Lot LOT-0012.
58. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €138,588 excl. VAT; Tenders received: 3; Lot LOT-0012.
59. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €68,962 excl. VAT; Tenders received: 4; Lot LOT-0013.
60. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €68,962 excl. VAT; Tenders received: 4; Lot LOT-0013.
61. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €68,962 excl. VAT; Tenders received: 4; Lot LOT-0013.
62. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €68,962 excl. VAT; Tenders received: 4; Lot LOT-0013.
63. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €421,487 excl. VAT; Tenders received: 6; Lot LOT-0014.
64. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €421,487 excl. VAT; Tenders received: 6; Lot LOT-0014.
65. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €421,487 excl. VAT; Tenders received: 6; Lot LOT-0014.
66. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €421,487 excl. VAT; Tenders received: 6; Lot LOT-0014.
67. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €421,487 excl. VAT; Tenders received: 6; Lot LOT-0014.
68. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €421,487 excl. VAT; Tenders received: 6; Lot LOT-0014.
69. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,722,952 excl. VAT; Tenders received: 8; Lot LOT-0015.
70. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,722,952 excl. VAT; Tenders received: 8; Lot LOT-0015.
71. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,722,952 excl. VAT; Tenders received: 8; Lot LOT-0015.
72. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,722,952 excl. VAT; Tenders received: 8; Lot LOT-0015.
73. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €98,025 excl. VAT; Tenders received: 2; Lot LOT-0016.
74. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €98,025 excl. VAT; Tenders received: 2; Lot LOT-0016.
75. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €617,329 excl. VAT; Tenders received: 4; Lot LOT-0017.
76. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €617,329 excl. VAT; Tenders received: 4; Lot LOT-0017.
77. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €617,329 excl. VAT; Tenders received: 4; Lot LOT-0017.
78. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €617,329 excl. VAT; Tenders received: 4; Lot LOT-0017.
79. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €240,653 excl. VAT; Tenders received: 3; Lot LOT-0018.
80. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €240,653 excl. VAT; Tenders received: 3; Lot LOT-0018.
81. 8 July 2026: Award. Winner: Klinge Pharma GmbH; Award value: €156,449 excl. VAT; Tenders received: 1; Lot LOT-0019.
82. 8 July 2026: Award. Winner: Klinge Pharma GmbH; Award value: €156,449 excl. VAT; Tenders received: 1; Lot LOT-0019.
83. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €384,408 excl. VAT; Tenders received: 6; Lot LOT-0024.
84. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €384,408 excl. VAT; Tenders received: 6; Lot LOT-0024.
85. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €384,408 excl. VAT; Tenders received: 6; Lot LOT-0024.
86. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €384,408 excl. VAT; Tenders received: 6; Lot LOT-0024.
87. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €413,198 excl. VAT; Tenders received: 3; Lot LOT-0025.
88. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €413,198 excl. VAT; Tenders received: 3; Lot LOT-0025.
89. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €413,198 excl. VAT; Tenders received: 3; Lot LOT-0025.
90. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €413,198 excl. VAT; Tenders received: 3; Lot LOT-0025.
91. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €288,667 excl. VAT; Tenders received: 3; Lot LOT-0026.
92. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €288,667 excl. VAT; Tenders received: 3; Lot LOT-0026.
93. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €321,627 excl. VAT; Tenders received: 2; Lot LOT-0027.
94. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €321,627 excl. VAT; Tenders received: 2; Lot LOT-0027.
95. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €321,627 excl. VAT; Tenders received: 2; Lot LOT-0027.
96. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €321,627 excl. VAT; Tenders received: 2; Lot LOT-0027.
97. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,507,223 excl. VAT; Tenders received: 4; Lot LOT-0028.
98. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €2,507,223 excl. VAT; Tenders received: 4; Lot LOT-0028.
99. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,507,223 excl. VAT; Tenders received: 4; Lot LOT-0028.
100. 8 July 2026: Award. Winner: 028 | Bisoprolol Filmtabletten u.w. [3]; Award value: €2,507,223 excl. VAT; Tenders received: 4; Lot LOT-0028.
101. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €2,507,223 excl. VAT; Tenders received: 4; Lot LOT-0028.
102. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,507,223 excl. VAT; Tenders received: 4; Lot LOT-0028.
103. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,697,386 excl. VAT; Tenders received: 8; Lot LOT-0029.
104. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,697,386 excl. VAT; Tenders received: 8; Lot LOT-0029.
105. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,697,386 excl. VAT; Tenders received: 8; Lot LOT-0029.
106. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,697,386 excl. VAT; Tenders received: 8; Lot LOT-0029.
107. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €607,346 excl. VAT; Tenders received: 2; Lot LOT-0030.
108. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €607,346 excl. VAT; Tenders received: 2; Lot LOT-0030.
109. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €607,346 excl. VAT; Tenders received: 2; Lot LOT-0030.
110. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €607,346 excl. VAT; Tenders received: 2; Lot LOT-0030.
111. 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €298,162 excl. VAT; Tenders received: 2; Lot LOT-0031.
112. 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €298,162 excl. VAT; Tenders received: 2; Lot LOT-0031.
113. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €495,424 excl. VAT; Tenders received: 1; Lot LOT-0032.
114. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €495,424 excl. VAT; Tenders received: 1; Lot LOT-0032.
115. 8 July 2026: Award. Winner: ETHYPHARM GmbH; Award value: €34,183 excl. VAT; Tenders received: 1; Lot LOT-0033.
116. 8 July 2026: Award. Winner: ETHYPHARM GmbH; Award value: €34,183 excl. VAT; Tenders received: 1; Lot LOT-0033.
117. 8 July 2026: Award. Winner: Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH; Award value: €2,520,709 excl. VAT; Tenders received: 6; Lot LOT-0035.
118. 8 July 2026: Award. Winner: Basics GmbH; Award value: €2,520,709 excl. VAT; Tenders received: 6; Lot LOT-0035.
119. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,520,709 excl. VAT; Tenders received: 6; Lot LOT-0035.
120. 8 July 2026: Award. Winner: Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH; Award value: €2,520,709 excl. VAT; Tenders received: 6; Lot LOT-0035.
121. 8 July 2026: Award. Winner: Basics GmbH; Award value: €2,520,709 excl. VAT; Tenders received: 6; Lot LOT-0035.
122. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,520,709 excl. VAT; Tenders received: 6; Lot LOT-0035.
123. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €147,740 excl. VAT; Tenders received: 3; Lot LOT-0036.
124. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €147,740 excl. VAT; Tenders received: 3; Lot LOT-0036.
125. 8 July 2026: Award. Winner: Aristo Pharma GmbH; Award value: €2,038,709 excl. VAT; Tenders received: 4; Lot LOT-0037.
126. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,038,709 excl. VAT; Tenders received: 4; Lot LOT-0037.
127. 8 July 2026: Award. Winner: Aristo Pharma GmbH; Award value: €2,038,709 excl. VAT; Tenders received: 4; Lot LOT-0037.
128. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,038,709 excl. VAT; Tenders received: 4; Lot LOT-0037.
129. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,484,538 excl. VAT; Tenders received: 6; Lot LOT-0038.
130. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,484,538 excl. VAT; Tenders received: 6; Lot LOT-0038.
131. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,484,538 excl. VAT; Tenders received: 6; Lot LOT-0038.
132. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,484,538 excl. VAT; Tenders received: 6; Lot LOT-0038.
133. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,484,538 excl. VAT; Tenders received: 6; Lot LOT-0038.
134. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,484,538 excl. VAT; Tenders received: 6; Lot LOT-0038.
135. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €10,344,179 excl. VAT; Tenders received: 8; Lot LOT-0039.
136. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €10,344,179 excl. VAT; Tenders received: 8; Lot LOT-0039.
137. 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €10,344,179 excl. VAT; Tenders received: 8; Lot LOT-0039.
138. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €10,344,179 excl. VAT; Tenders received: 8; Lot LOT-0039.
139. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €10,344,179 excl. VAT; Tenders received: 8; Lot LOT-0039.
140. 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €10,344,179 excl. VAT; Tenders received: 8; Lot LOT-0039.
141. 8 July 2026: Award. Winner: Recordati Rare Diseases Germany GmbH; Award value: €1,415,752 excl. VAT; Tenders received: 2; Lot LOT-0040.
142. 8 July 2026: Award. Winner: Recordati Rare Diseases Germany GmbH; Award value: €1,415,752 excl. VAT; Tenders received: 2; Lot LOT-0040.
143. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €657,846 excl. VAT; Tenders received: 4; Lot LOT-0041.
144. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €657,846 excl. VAT; Tenders received: 4; Lot LOT-0041.
145. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €657,846 excl. VAT; Tenders received: 4; Lot LOT-0041.
146. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €657,846 excl. VAT; Tenders received: 4; Lot LOT-0041.
147. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €657,846 excl. VAT; Tenders received: 4; Lot LOT-0041.
148. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €657,846 excl. VAT; Tenders received: 4; Lot LOT-0041.
149. 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €804,717 excl. VAT; Tenders received: 1; Lot LOT-0042.
150. 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €804,717 excl. VAT; Tenders received: 1; Lot LOT-0042.
151. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €61,190 excl. VAT; Tenders received: 6; Lot LOT-0043.
152. 8 July 2026: Award. Winner: Hormosan Pharma Gesellschaft mit beschränkter Haftung; Award value: €61,190 excl. VAT; Tenders received: 6; Lot LOT-0043.
153. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €61,190 excl. VAT; Tenders received: 6; Lot LOT-0043.
154. 8 July 2026: Award. Winner: Hormosan Pharma Gesellschaft mit beschränkter Haftung; Award value: €61,190 excl. VAT; Tenders received: 6; Lot LOT-0043.
155. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €781,122 excl. VAT; Tenders received: 5; Lot LOT-0044.
156. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €781,122 excl. VAT; Tenders received: 5; Lot LOT-0044.
157. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €781,122 excl. VAT; Tenders received: 5; Lot LOT-0044.
158. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €781,122 excl. VAT; Tenders received: 5; Lot LOT-0044.
159. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €781,122 excl. VAT; Tenders received: 5; Lot LOT-0044.
160. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €781,122 excl. VAT; Tenders received: 5; Lot LOT-0044.
161. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €1,208,950 excl. VAT; Tenders received: 11; Lot LOT-0045.
162. 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €1,208,950 excl. VAT; Tenders received: 11; Lot LOT-0045.
163. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €1,208,950 excl. VAT; Tenders received: 11; Lot LOT-0045.
164. 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €1,208,950 excl. VAT; Tenders received: 11; Lot LOT-0045.
165. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €898,442 excl. VAT; Tenders received: 4; Lot LOT-0046.
166. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €898,442 excl. VAT; Tenders received: 4; Lot LOT-0046.
167. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €898,442 excl. VAT; Tenders received: 4; Lot LOT-0046.
168. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €898,442 excl. VAT; Tenders received: 4; Lot LOT-0046.
169. 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €94,877 excl. VAT; Tenders received: 2; Lot LOT-0048.
170. 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €94,877 excl. VAT; Tenders received: 2; Lot LOT-0048.
171. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €278,904 excl. VAT; Tenders received: 1; Lot LOT-0049.
172. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €278,904 excl. VAT; Tenders received: 1; Lot LOT-0049.
173. 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €206,196 excl. VAT; Tenders received: 4; Lot LOT-0050.
174. 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €206,196 excl. VAT; Tenders received: 4; Lot LOT-0050.
175. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €24,569 excl. VAT; Tenders received: 2; Lot LOT-0051.
176. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €24,569 excl. VAT; Tenders received: 2; Lot LOT-0051.
177. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €921,005 excl. VAT; Tenders received: 9; Lot LOT-0052.
178. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €921,005 excl. VAT; Tenders received: 9; Lot LOT-0052.
179. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €921,005 excl. VAT; Tenders received: 9; Lot LOT-0052.
180. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €921,005 excl. VAT; Tenders received: 9; Lot LOT-0052.
181. 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €366,029 excl. VAT; Tenders received: 6; Lot LOT-0053.
182. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €366,029 excl. VAT; Tenders received: 6; Lot LOT-0053.
183. 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €366,029 excl. VAT; Tenders received: 6; Lot LOT-0053.
184. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €366,029 excl. VAT; Tenders received: 6; Lot LOT-0053.
185. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,311,167 excl. VAT; Tenders received: 8; Lot LOT-0054.
186. 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €1,311,167 excl. VAT; Tenders received: 8; Lot LOT-0054.
187. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,311,167 excl. VAT; Tenders received: 8; Lot LOT-0054.
188. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,311,167 excl. VAT; Tenders received: 8; Lot LOT-0054.
189. 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €1,311,167 excl. VAT; Tenders received: 8; Lot LOT-0054.
190. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,311,167 excl. VAT; Tenders received: 8; Lot LOT-0054.
191. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €591,888 excl. VAT; Tenders received: 1; Lot LOT-0055.
192. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €591,888 excl. VAT; Tenders received: 1; Lot LOT-0055.
193. 8 July 2026: Award. Winner: Devatis GmbH; Award value: €36,558 excl. VAT; Tenders received: 3; Lot LOT-0056.
194. 8 July 2026: Award. Winner: Devatis GmbH; Award value: €36,558 excl. VAT; Tenders received: 3; Lot LOT-0056.
195. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,064,137 excl. VAT; Tenders received: 4; Lot LOT-0057.
196. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,064,137 excl. VAT; Tenders received: 4; Lot LOT-0057.
197. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €68,370 excl. VAT; Tenders received: 3; Lot LOT-0058.
198. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €68,370 excl. VAT; Tenders received: 3; Lot LOT-0058.
199. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €68,370 excl. VAT; Tenders received: 3; Lot LOT-0058.
200. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €68,370 excl. VAT; Tenders received: 3; Lot LOT-0058.
201. 8 July 2026: Award. Winner: Bayer Vital GmbH; Award value: €212,378 excl. VAT; Tenders received: 4; Lot LOT-0059.
202. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €212,378 excl. VAT; Tenders received: 4; Lot LOT-0059.
203. 8 July 2026: Award. Winner: Bayer Vital GmbH; Award value: €212,378 excl. VAT; Tenders received: 4; Lot LOT-0059.
204. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €212,378 excl. VAT; Tenders received: 4; Lot LOT-0059.
205. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €572,176 excl. VAT; Tenders received: 7; Lot LOT-0060.
206. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €572,176 excl. VAT; Tenders received: 7; Lot LOT-0060.
207. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €572,176 excl. VAT; Tenders received: 7; Lot LOT-0060.
208. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €572,176 excl. VAT; Tenders received: 7; Lot LOT-0060.
209. 8 July 2026: Award. Winner: AAA-Pharma GmbH; Award value: €204,369 excl. VAT; Tenders received: 2; Lot LOT-0061.
210. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €204,369 excl. VAT; Tenders received: 2; Lot LOT-0061.
211. 8 July 2026: Award. Winner: AAA-Pharma GmbH; Award value: €204,369 excl. VAT; Tenders received: 2; Lot LOT-0061.
212. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €204,369 excl. VAT; Tenders received: 2; Lot LOT-0061.
213. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €595,598 excl. VAT; Tenders received: 5; Lot LOT-0062.
214. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €595,598 excl. VAT; Tenders received: 5; Lot LOT-0062.
215. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €595,598 excl. VAT; Tenders received: 5; Lot LOT-0062.
216. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €595,598 excl. VAT; Tenders received: 5; Lot LOT-0062.
217. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €302,485 excl. VAT; Tenders received: 2; Lot LOT-0063.
218. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €302,485 excl. VAT; Tenders received: 2; Lot LOT-0063.
219. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €302,485 excl. VAT; Tenders received: 2; Lot LOT-0063.
220. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €302,485 excl. VAT; Tenders received: 2; Lot LOT-0063.
221. 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €89,581 excl. VAT; Tenders received: 3; Lot LOT-0064.
222. 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €89,581 excl. VAT; Tenders received: 3; Lot LOT-0064.
223. 8 July 2026: Award. Winner: Abdi Farma GmbH; Award value: €899,552 excl. VAT; Tenders received: 11; Lot LOT-0065.
224. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €899,552 excl. VAT; Tenders received: 11; Lot LOT-0065.
225. 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €899,552 excl. VAT; Tenders received: 11; Lot LOT-0065.
226. 8 July 2026: Award. Winner: Abdi Farma GmbH; Award value: €899,552 excl. VAT; Tenders received: 11; Lot LOT-0065.
227. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €899,552 excl. VAT; Tenders received: 11; Lot LOT-0065.
228. 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €899,552 excl. VAT; Tenders received: 11; Lot LOT-0065.
229. 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €512,606 excl. VAT; Tenders received: 7; Lot LOT-0066.
230. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €512,606 excl. VAT; Tenders received: 7; Lot LOT-0066.
231. 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €512,606 excl. VAT; Tenders received: 7; Lot LOT-0066.
232. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €512,606 excl. VAT; Tenders received: 7; Lot LOT-0066.
233. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €190,024 excl. VAT; Tenders received: 4; Lot LOT-0067.
234. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €190,024 excl. VAT; Tenders received: 4; Lot LOT-0067.
235. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €190,024 excl. VAT; Tenders received: 4; Lot LOT-0067.
236. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €190,024 excl. VAT; Tenders received: 4; Lot LOT-0067.
237. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €497,502 excl. VAT; Tenders received: 5; Lot LOT-0068.
238. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €497,502 excl. VAT; Tenders received: 5; Lot LOT-0068.
239. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €497,502 excl. VAT; Tenders received: 5; Lot LOT-0068.
240. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €497,502 excl. VAT; Tenders received: 5; Lot LOT-0068.
241. 8 July 2026: Award. Winner: ROVI GmbH; Award value: €5,397,408 excl. VAT; Tenders received: 5; Lot LOT-0069.
242. 8 July 2026: Award. Winner: Venipharm S.A.S. vertreten durch Venipharm GmbH; Award value: €5,397,408 excl. VAT; Tenders received: 5; Lot LOT-0069.
243. 8 July 2026: Award. Winner: ROVI GmbH; Award value: €5,397,408 excl. VAT; Tenders received: 5; Lot LOT-0069.
244. 8 July 2026: Award. Winner: Venipharm S.A.S. vertreten durch Venipharm GmbH; Award value: €5,397,408 excl. VAT; Tenders received: 5; Lot LOT-0069.
245. 8 July 2026: Award. Winner: HEC Pharm GmbH; Award value: €39,122 excl. VAT; Tenders received: 1; Lot LOT-0070.
246. 8 July 2026: Award. Winner: HEC Pharm GmbH; Award value: €39,122 excl. VAT; Tenders received: 1; Lot LOT-0070.
247. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €298,737 excl. VAT; Tenders received: 6; Lot LOT-0071.
248. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €298,737 excl. VAT; Tenders received: 6; Lot LOT-0071.
249. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €298,737 excl. VAT; Tenders received: 6; Lot LOT-0071.
250. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €298,737 excl. VAT; Tenders received: 6; Lot LOT-0071.
251. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €37,223 excl. VAT; Tenders received: 1; Lot LOT-0072.
252. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €37,223 excl. VAT; Tenders received: 1; Lot LOT-0072.
253. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €254,039 excl. VAT; Tenders received: 7; Lot LOT-0073.
254. 8 July 2026: Award. Winner: Ascend GmbH; Award value: €254,039 excl. VAT; Tenders received: 7; Lot LOT-0073.
255. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €254,039 excl. VAT; Tenders received: 7; Lot LOT-0073.
256. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €254,039 excl. VAT; Tenders received: 7; Lot LOT-0073.
257. 8 July 2026: Award. Winner: Ascend GmbH; Award value: €254,039 excl. VAT; Tenders received: 7; Lot LOT-0073.
258. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €254,039 excl. VAT; Tenders received: 7; Lot LOT-0073.
259. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €102,983 excl. VAT; Tenders received: 2; Lot LOT-0074.
260. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €102,983 excl. VAT; Tenders received: 2; Lot LOT-0074.
261. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €102,983 excl. VAT; Tenders received: 2; Lot LOT-0074.
262. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €102,983 excl. VAT; Tenders received: 2; Lot LOT-0074.
263. 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €1,962,275 excl. VAT; Tenders received: 8; Lot LOT-0075.
264. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €1,962,275 excl. VAT; Tenders received: 8; Lot LOT-0075.
265. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,962,275 excl. VAT; Tenders received: 8; Lot LOT-0075.
266. 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €1,962,275 excl. VAT; Tenders received: 8; Lot LOT-0075.
267. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €1,962,275 excl. VAT; Tenders received: 8; Lot LOT-0075.
268. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,962,275 excl. VAT; Tenders received: 8; Lot LOT-0075.
269. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €270,507 excl. VAT; Tenders received: 7; Lot LOT-0076.
270. 8 July 2026: Award. Winner: BIOCON PHARMA MALTA I LIMITED; Award value: €270,507 excl. VAT; Tenders received: 7; Lot LOT-0076.
271. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €270,507 excl. VAT; Tenders received: 7; Lot LOT-0076.
272. 8 July 2026: Award. Winner: BIOCON PHARMA MALTA I LIMITED; Award value: €270,507 excl. VAT; Tenders received: 7; Lot LOT-0076.
273. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €258,507 excl. VAT; Tenders received: 6; Lot LOT-0077.
274. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €258,507 excl. VAT; Tenders received: 6; Lot LOT-0077.
275. 8 July 2026: Award. Winner: Devatis GmbH; Award value: €258,507 excl. VAT; Tenders received: 6; Lot LOT-0077.
276. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €258,507 excl. VAT; Tenders received: 6; Lot LOT-0077.
277. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €258,507 excl. VAT; Tenders received: 6; Lot LOT-0077.
278. 8 July 2026: Award. Winner: Devatis GmbH; Award value: €258,507 excl. VAT; Tenders received: 6; Lot LOT-0077.
279. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €332,751 excl. VAT; Tenders received: 6; Lot LOT-0079.
280. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €332,751 excl. VAT; Tenders received: 6; Lot LOT-0079.
281. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €332,751 excl. VAT; Tenders received: 6; Lot LOT-0079.
282. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €332,751 excl. VAT; Tenders received: 6; Lot LOT-0079.
283. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €332,751 excl. VAT; Tenders received: 6; Lot LOT-0079.
284. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €332,751 excl. VAT; Tenders received: 6; Lot LOT-0079.
285. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €254,081 excl. VAT; Tenders received: 4; Lot LOT-0080.
286. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €254,081 excl. VAT; Tenders received: 4; Lot LOT-0080.
287. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €254,081 excl. VAT; Tenders received: 4; Lot LOT-0080.
288. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €254,081 excl. VAT; Tenders received: 4; Lot LOT-0080.
289. 8 July 2026: Award. Winner: Phoenix Labs Unlimited Company; Award value: €48,375 excl. VAT; Tenders received: 1; Lot LOT-0081.
290. 8 July 2026: Award. Winner: Phoenix Labs Unlimited Company; Award value: €48,375 excl. VAT; Tenders received: 1; Lot LOT-0081.
291. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €822,136 excl. VAT; Tenders received: 3; Lot LOT-0082.
292. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €822,136 excl. VAT; Tenders received: 3; Lot LOT-0082.
293. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €822,136 excl. VAT; Tenders received: 3; Lot LOT-0082.
294. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €822,136 excl. VAT; Tenders received: 3; Lot LOT-0082.
295. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €40,508 excl. VAT; Tenders received: 1; Lot LOT-0083.
296. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €40,508 excl. VAT; Tenders received: 1; Lot LOT-0083.
297. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €757,139 excl. VAT; Tenders received: 2; Lot LOT-0084.
298. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €757,139 excl. VAT; Tenders received: 2; Lot LOT-0084.
299. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €385,841 excl. VAT; Tenders received: 2; Lot LOT-0085.
300. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €385,841 excl. VAT; Tenders received: 2; Lot LOT-0085.
301. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €385,841 excl. VAT; Tenders received: 2; Lot LOT-0085.
302. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €385,841 excl. VAT; Tenders received: 2; Lot LOT-0085.
303. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €639,231 excl. VAT; Tenders received: 9; Lot LOT-0086.
304. 8 July 2026: Award. Winner: Ascend GmbH; Award value: €639,231 excl. VAT; Tenders received: 9; Lot LOT-0086.
305. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €639,231 excl. VAT; Tenders received: 9; Lot LOT-0086.
306. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €639,231 excl. VAT; Tenders received: 9; Lot LOT-0086.
307. 8 July 2026: Award. Winner: Ascend GmbH; Award value: €639,231 excl. VAT; Tenders received: 9; Lot LOT-0086.
308. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €639,231 excl. VAT; Tenders received: 9; Lot LOT-0086.
309. 8 July 2026: Award. Winner: Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH; Award value: €744,475 excl. VAT; Tenders received: 6; Lot LOT-0087.
310. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €744,475 excl. VAT; Tenders received: 6; Lot LOT-0087.
311. 8 July 2026: Award. Winner: Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH; Award value: €744,475 excl. VAT; Tenders received: 6; Lot LOT-0087.
312. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €744,475 excl. VAT; Tenders received: 6; Lot LOT-0087.
313. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €486,208 excl. VAT; Tenders received: 4; Lot LOT-0089.
314. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €486,208 excl. VAT; Tenders received: 4; Lot LOT-0089.
315. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €486,208 excl. VAT; Tenders received: 4; Lot LOT-0089.
316. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €486,208 excl. VAT; Tenders received: 4; Lot LOT-0089.
317. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €486,208 excl. VAT; Tenders received: 4; Lot LOT-0089.
318. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €486,208 excl. VAT; Tenders received: 4; Lot LOT-0089.
319. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €10,205,410 excl. VAT; Tenders received: 5; Lot LOT-0090.
320. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €10,205,410 excl. VAT; Tenders received: 5; Lot LOT-0090.
321. 8 July 2026: Award. Winner: Hormosan Pharma Gesellschaft mit beschränkter Haftung; Award value: €10,205,410 excl. VAT; Tenders received: 5; Lot LOT-0090.
322. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €10,205,410 excl. VAT; Tenders received: 5; Lot LOT-0090.
323. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €10,205,410 excl. VAT; Tenders received: 5; Lot LOT-0090.
324. 8 July 2026: Award. Winner: Hormosan Pharma Gesellschaft mit beschränkter Haftung; Award value: €10,205,410 excl. VAT; Tenders received: 5; Lot LOT-0090.
325. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €317,262 excl. VAT; Tenders received: 3; Lot LOT-0091.
326. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €317,262 excl. VAT; Tenders received: 3; Lot LOT-0091.
327. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €493,124 excl. VAT; Tenders received: 8; Lot LOT-0092.
328. 8 July 2026: Award. Winner: EVER Pharma GmbH; Award value: €493,124 excl. VAT; Tenders received: 8; Lot LOT-0092.
329. 8 July 2026: Award. Winner: HIKMA PHARMA GMBH; Award value: €493,124 excl. VAT; Tenders received: 8; Lot LOT-0092.
330. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €493,124 excl. VAT; Tenders received: 8; Lot LOT-0092.
331. 8 July 2026: Award. Winner: EVER Pharma GmbH; Award value: €493,124 excl. VAT; Tenders received: 8; Lot LOT-0092.
332. 8 July 2026: Award. Winner: HIKMA PHARMA GMBH; Award value: €493,124 excl. VAT; Tenders received: 8; Lot LOT-0092.
333. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €234,536 excl. VAT; Tenders received: 2; Lot LOT-0093.
334. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €234,536 excl. VAT; Tenders received: 2; Lot LOT-0093.
335. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €234,536 excl. VAT; Tenders received: 2; Lot LOT-0093.
336. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €234,536 excl. VAT; Tenders received: 2; Lot LOT-0093.
337. 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €52,700 excl. VAT; Tenders received: 1; Lot LOT-0094.
338. 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €52,700 excl. VAT; Tenders received: 1; Lot LOT-0094.
339. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €259,427 excl. VAT; Tenders received: 4; Lot LOT-0095.
340. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €259,427 excl. VAT; Tenders received: 4; Lot LOT-0095.
341. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €259,427 excl. VAT; Tenders received: 4; Lot LOT-0095.
342. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €259,427 excl. VAT; Tenders received: 4; Lot LOT-0095.
343. 8 July 2026: Award. Winner: Takeda GmbH; Award value: €1,292,206 excl. VAT; Tenders received: 2; Lot LOT-0096.
344. 8 July 2026: Award. Winner: Takeda GmbH; Award value: €1,292,206 excl. VAT; Tenders received: 2; Lot LOT-0096.
345. 8 July 2026: Award. Winner: mibe GmbH Arzneimittel; Award value: €557,745 excl. VAT; Tenders received: 4; Lot LOT-0098.
346. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €557,745 excl. VAT; Tenders received: 4; Lot LOT-0098.
347. 8 July 2026: Award. Winner: mibe GmbH Arzneimittel; Award value: €557,745 excl. VAT; Tenders received: 4; Lot LOT-0098.
348. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €557,745 excl. VAT; Tenders received: 4; Lot LOT-0098.
349. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €1,306,758 excl. VAT; Tenders received: 3; Lot LOT-0099.
350. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,306,758 excl. VAT; Tenders received: 3; Lot LOT-0099.
351. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €1,306,758 excl. VAT; Tenders received: 3; Lot LOT-0099.
352. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,306,758 excl. VAT; Tenders received: 3; Lot LOT-0099.
353. 8 July 2026: Award. Winner: Devatis GmbH; Award value: €340,103 excl. VAT; Tenders received: 4; Lot LOT-0100.
354. 8 July 2026: Award. Winner: Medac Gesellschaft für klinische Spezialpräparate m.b.H.; Award value: €340,103 excl. VAT; Tenders received: 4; Lot LOT-0100.
355. 8 July 2026: Award. Winner: Devatis GmbH; Award value: €340,103 excl. VAT; Tenders received: 4; Lot LOT-0100.
356. 8 July 2026: Award. Winner: Medac Gesellschaft für klinische Spezialpräparate m.b.H.; Award value: €340,103 excl. VAT; Tenders received: 4; Lot LOT-0100.
357. 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €26,220 excl. VAT; Tenders received: 1; Lot LOT-0101.
358. 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €26,220 excl. VAT; Tenders received: 1; Lot LOT-0101.
359. 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €129,389 excl. VAT; Tenders received: 3; Lot LOT-0102.
360. 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €129,389 excl. VAT; Tenders received: 3; Lot LOT-0102.
361. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €105,572 excl. VAT; Tenders received: 1; Lot LOT-0103.
362. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €105,572 excl. VAT; Tenders received: 1; Lot LOT-0103.
363. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €322,663 excl. VAT; Tenders received: 3; Lot LOT-0104.
364. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €322,663 excl. VAT; Tenders received: 3; Lot LOT-0104.
365. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €322,663 excl. VAT; Tenders received: 3; Lot LOT-0104.
366. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €322,663 excl. VAT; Tenders received: 3; Lot LOT-0104.
367. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,283,399 excl. VAT; Tenders received: 5; Lot LOT-0105.
368. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,283,399 excl. VAT; Tenders received: 5; Lot LOT-0105.
369. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,283,399 excl. VAT; Tenders received: 5; Lot LOT-0105.
370. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,283,399 excl. VAT; Tenders received: 5; Lot LOT-0105.
371. 8 July 2026: Award. Winner: Basics GmbH; Award value: €365,756 excl. VAT; Tenders received: 2; Lot LOT-0106.
372. 8 July 2026: Award. Winner: Basics GmbH; Award value: €365,756 excl. VAT; Tenders received: 2; Lot LOT-0106.
373. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €84,168 excl. VAT; Tenders received: 1; Lot LOT-0107.
374. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €84,168 excl. VAT; Tenders received: 1; Lot LOT-0107.
375. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €153,411 excl. VAT; Tenders received: 7; Lot LOT-0108.
376. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €153,411 excl. VAT; Tenders received: 7; Lot LOT-0108.
377. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €153,411 excl. VAT; Tenders received: 7; Lot LOT-0108.
378. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €153,411 excl. VAT; Tenders received: 7; Lot LOT-0108.
379. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €153,411 excl. VAT; Tenders received: 7; Lot LOT-0108.
380. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €153,411 excl. VAT; Tenders received: 7; Lot LOT-0108.
381. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €39,175 excl. VAT; Tenders received: 1; Lot LOT-0109.
382. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €39,175 excl. VAT; Tenders received: 1; Lot LOT-0109.
383. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €75,247 excl. VAT; Tenders received: 3; Lot LOT-0111.
384. 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €75,247 excl. VAT; Tenders received: 3; Lot LOT-0111.
385. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €75,247 excl. VAT; Tenders received: 3; Lot LOT-0111.
386. 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €75,247 excl. VAT; Tenders received: 3; Lot LOT-0111.
387. 8 July 2026: Award. Winner: Takeda GmbH; Award value: €551,748 excl. VAT; Tenders received: 1; Lot LOT-0112.
388. 8 July 2026: Award. Winner: Takeda GmbH; Award value: €551,748 excl. VAT; Tenders received: 1; Lot LOT-0112.
389. 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €1,212,252 excl. VAT; Tenders received: 4; Lot LOT-0113.
390. 8 July 2026: Award. Winner: OmniVision; Award value: €1,212,252 excl. VAT; Tenders received: 4; Lot LOT-0113.
391. 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €1,212,252 excl. VAT; Tenders received: 4; Lot LOT-0113.
392. 8 July 2026: Award. Winner: OmniVision; Award value: €1,212,252 excl. VAT; Tenders received: 4; Lot LOT-0113.
393. 8 July 2026: Award. Winner: Laboratoires THEA S.A.S. vertreten durch Théa Pharma GmbH; Award value: €1,272,238 excl. VAT; Tenders received: 2; Lot LOT-0114.
394. 8 July 2026: Award. Winner: Laboratoires THEA S.A.S. vertreten durch Théa Pharma GmbH; Award value: €1,272,238 excl. VAT; Tenders received: 2; Lot LOT-0114.
395. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,431,277 excl. VAT; Tenders received: 7; Lot LOT-0115.
396. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,431,277 excl. VAT; Tenders received: 7; Lot LOT-0115.
397. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,431,277 excl. VAT; Tenders received: 7; Lot LOT-0115.
398. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,431,277 excl. VAT; Tenders received: 7; Lot LOT-0115.
399. 8 July 2026: Award. Winner: Devatis GmbH; Award value: €398,282 excl. VAT; Tenders received: 11; Lot LOT-0116.
400. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €398,282 excl. VAT; Tenders received: 11; Lot LOT-0116.
401. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €398,282 excl. VAT; Tenders received: 11; Lot LOT-0116.
402. 8 July 2026: Award. Winner: Devatis GmbH; Award value: €398,282 excl. VAT; Tenders received: 11; Lot LOT-0116.
403. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €398,282 excl. VAT; Tenders received: 11; Lot LOT-0116.
404. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €398,282 excl. VAT; Tenders received: 11; Lot LOT-0116.
405. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €654,598 excl. VAT; Tenders received: 11; Lot LOT-0117.
406. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €654,598 excl. VAT; Tenders received: 11; Lot LOT-0117.
407. 8 July 2026: Award. Winner: Sun Pharmaceuticals Germany GmbH; Award value: €654,598 excl. VAT; Tenders received: 11; Lot LOT-0117.
408. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €654,598 excl. VAT; Tenders received: 11; Lot LOT-0117.
409. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €654,598 excl. VAT; Tenders received: 11; Lot LOT-0117.
410. 8 July 2026: Award. Winner: Sun Pharmaceuticals Germany GmbH; Award value: €654,598 excl. VAT; Tenders received: 11; Lot LOT-0117.
411. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €2,352,368 excl. VAT; Tenders received: 9; Lot LOT-0118.
412. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €2,352,368 excl. VAT; Tenders received: 9; Lot LOT-0118.
413. 8 July 2026: Award. Winner: Hormosan Pharma GmbH; Award value: €2,352,368 excl. VAT; Tenders received: 9; Lot LOT-0118.
414. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €2,352,368 excl. VAT; Tenders received: 9; Lot LOT-0118.
415. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €2,352,368 excl. VAT; Tenders received: 9; Lot LOT-0118.
416. 8 July 2026: Award. Winner: Hormosan Pharma GmbH; Award value: €2,352,368 excl. VAT; Tenders received: 9; Lot LOT-0118.
417. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €34,605 excl. VAT; Tenders received: 2; Lot LOT-0120.
418. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €34,605 excl. VAT; Tenders received: 2; Lot LOT-0120.
419. 8 July 2026: Award. Winner: Devatis GmbH; Award value: €797,847 excl. VAT; Tenders received: 1; Lot LOT-0121.
420. 8 July 2026: Award. Winner: Devatis GmbH; Award value: €797,847 excl. VAT; Tenders received: 1; Lot LOT-0121.
421. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €281,402 excl. VAT; Tenders received: 3; Lot LOT-0122.
422. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €281,402 excl. VAT; Tenders received: 3; Lot LOT-0122.
423. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €281,402 excl. VAT; Tenders received: 3; Lot LOT-0122.
424. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €281,402 excl. VAT; Tenders received: 3; Lot LOT-0122.
425. 8 July 2026: Award. Winner: Exeltis Germany GmbH; Award value: €323,662 excl. VAT; Tenders received: 4; Lot LOT-0123.
426. 8 July 2026: Award. Winner: Hormosan Pharma Gesellschaft mit beschränkter Haftung; Award value: €323,662 excl. VAT; Tenders received: 4; Lot LOT-0123.
427. 8 July 2026: Award. Winner: Exeltis Germany GmbH; Award value: €323,662 excl. VAT; Tenders received: 4; Lot LOT-0123.
428. 8 July 2026: Award. Winner: Hormosan Pharma Gesellschaft mit beschränkter Haftung; Award value: €323,662 excl. VAT; Tenders received: 4; Lot LOT-0123.
429. 8 July 2026: Award. Winner: Bayer Vital GmbH; Award value: €141,550 excl. VAT; Tenders received: 3; Lot LOT-0124.
430. 8 July 2026: Award. Winner: Exeltis Germany GmbH; Award value: €141,550 excl. VAT; Tenders received: 3; Lot LOT-0124.
431. 8 July 2026: Award. Winner: Bayer Vital GmbH; Award value: €141,550 excl. VAT; Tenders received: 3; Lot LOT-0124.
432. 8 July 2026: Award. Winner: Exeltis Germany GmbH; Award value: €141,550 excl. VAT; Tenders received: 3; Lot LOT-0124.
433. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €3,777,219 excl. VAT; Tenders received: 2; Lot LOT-0125.
434. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €3,777,219 excl. VAT; Tenders received: 2; Lot LOT-0125.
435. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €3,777,219 excl. VAT; Tenders received: 2; Lot LOT-0125.
436. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €3,777,219 excl. VAT; Tenders received: 2; Lot LOT-0125.
437. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €189,292 excl. VAT; Tenders received: 4; Lot LOT-0126.
438. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €189,292 excl. VAT; Tenders received: 4; Lot LOT-0126.
439. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €189,292 excl. VAT; Tenders received: 4; Lot LOT-0126.
440. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €189,292 excl. VAT; Tenders received: 4; Lot LOT-0126.
441. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €233,342 excl. VAT; Tenders received: 3; Lot LOT-0127.
442. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €233,342 excl. VAT; Tenders received: 3; Lot LOT-0127.
443. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €233,342 excl. VAT; Tenders received: 3; Lot LOT-0127.
444. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €233,342 excl. VAT; Tenders received: 3; Lot LOT-0127.
445. 8 July 2026: Award. Winner: Pfizer Pharma GmbH; Award value: €285,774 excl. VAT; Tenders received: 3; Lot LOT-0128.
446. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €285,774 excl. VAT; Tenders received: 3; Lot LOT-0128.
447. 8 July 2026: Award. Winner: Pfizer Pharma GmbH; Award value: €285,774 excl. VAT; Tenders received: 3; Lot LOT-0128.
448. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €285,774 excl. VAT; Tenders received: 3; Lot LOT-0128.
449. 8 July 2026: Award. Winner: Ferring Arzneimittel GmbH; Award value: €759,356 excl. VAT; Tenders received: 4; Lot LOT-0130.
450. 8 July 2026: Award. Winner: Tillotts Pharma GmbH; Award value: €759,356 excl. VAT; Tenders received: 4; Lot LOT-0130.
451. 8 July 2026: Award. Winner: Ferring Arzneimittel GmbH; Award value: €759,356 excl. VAT; Tenders received: 4; Lot LOT-0130.
452. 8 July 2026: Award. Winner: Tillotts Pharma GmbH; Award value: €759,356 excl. VAT; Tenders received: 4; Lot LOT-0130.
453. 8 July 2026: Award. Winner: Dr. Falk Pharma GmbH; Award value: €781,708 excl. VAT; Tenders received: 2; Lot LOT-0131.
454. 8 July 2026: Award. Winner: Dr. Falk Pharma GmbH; Award value: €781,708 excl. VAT; Tenders received: 2; Lot LOT-0131.
455. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €4,776,515 excl. VAT; Tenders received: 3; Lot LOT-0132.
456. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €4,776,515 excl. VAT; Tenders received: 3; Lot LOT-0132.
457. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €4,776,515 excl. VAT; Tenders received: 3; Lot LOT-0132.
458. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €4,776,515 excl. VAT; Tenders received: 3; Lot LOT-0132.
459. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,412,194 excl. VAT; Tenders received: 3; Lot LOT-0133.
460. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,412,194 excl. VAT; Tenders received: 3; Lot LOT-0133.
461. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,412,194 excl. VAT; Tenders received: 3; Lot LOT-0133.
462. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,412,194 excl. VAT; Tenders received: 3; Lot LOT-0133.
463. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €3,356,442 excl. VAT; Tenders received: 8; Lot LOT-0134.
464. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,356,442 excl. VAT; Tenders received: 8; Lot LOT-0134.
465. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,356,442 excl. VAT; Tenders received: 8; Lot LOT-0134.
466. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €3,356,442 excl. VAT; Tenders received: 8; Lot LOT-0134.
467. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,356,442 excl. VAT; Tenders received: 8; Lot LOT-0134.
468. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,356,442 excl. VAT; Tenders received: 8; Lot LOT-0134.
469. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €2,001,479 excl. VAT; Tenders received: 6; Lot LOT-0135.
470. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €2,001,479 excl. VAT; Tenders received: 6; Lot LOT-0135.
471. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €2,001,479 excl. VAT; Tenders received: 6; Lot LOT-0135.
472. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €2,001,479 excl. VAT; Tenders received: 6; Lot LOT-0135.
473. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €146,102 excl. VAT; Tenders received: 1; Lot LOT-0136.
474. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €146,102 excl. VAT; Tenders received: 1; Lot LOT-0136.
475. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,008,468 excl. VAT; Tenders received: 5; Lot LOT-0137.
476. 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €1,008,468 excl. VAT; Tenders received: 5; Lot LOT-0137.
477. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,008,468 excl. VAT; Tenders received: 5; Lot LOT-0137.
478. 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €1,008,468 excl. VAT; Tenders received: 5; Lot LOT-0137.
479. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,618,070 excl. VAT; Tenders received: 4; Lot LOT-0138.
480. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €3,618,070 excl. VAT; Tenders received: 4; Lot LOT-0138.
481. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,618,070 excl. VAT; Tenders received: 4; Lot LOT-0138.
482. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €3,618,070 excl. VAT; Tenders received: 4; Lot LOT-0138.
483. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €176,572 excl. VAT; Tenders received: 3; Lot LOT-0140.
484. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €176,572 excl. VAT; Tenders received: 3; Lot LOT-0140.
485. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €176,572 excl. VAT; Tenders received: 3; Lot LOT-0140.
486. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €176,572 excl. VAT; Tenders received: 3; Lot LOT-0140.
487. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €197,032 excl. VAT; Tenders received: 1; Lot LOT-0141.
488. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €197,032 excl. VAT; Tenders received: 1; Lot LOT-0141.
489. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €72,539 excl. VAT; Tenders received: 2; Lot LOT-0142.
490. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €72,539 excl. VAT; Tenders received: 2; Lot LOT-0142.
491. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €75,406 excl. VAT; Tenders received: 2; Lot LOT-0143.
492. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €75,406 excl. VAT; Tenders received: 2; Lot LOT-0143.
493. 8 July 2026: Award. Winner: nio Health GmbH; Award value: €665,363 excl. VAT; Tenders received: 3; Lot LOT-0144.
494. 8 July 2026: Award. Winner: Pfizer Pharma GmbH; Award value: €665,363 excl. VAT; Tenders received: 3; Lot LOT-0144.
495. 8 July 2026: Award. Winner: nio Health GmbH; Award value: €665,363 excl. VAT; Tenders received: 3; Lot LOT-0144.
496. 8 July 2026: Award. Winner: Pfizer Pharma GmbH; Award value: €665,363 excl. VAT; Tenders received: 3; Lot LOT-0144.
497. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €2,300,359 excl. VAT; Tenders received: 11; Lot LOT-0145.
498. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,300,359 excl. VAT; Tenders received: 11; Lot LOT-0145.
499. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,300,359 excl. VAT; Tenders received: 11; Lot LOT-0145.
500. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €2,300,359 excl. VAT; Tenders received: 11; Lot LOT-0145.
501. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,300,359 excl. VAT; Tenders received: 11; Lot LOT-0145.
502. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €2,300,359 excl. VAT; Tenders received: 11; Lot LOT-0145.
503. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €632,835 excl. VAT; Tenders received: 5; Lot LOT-0146.
504. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €632,835 excl. VAT; Tenders received: 5; Lot LOT-0146.
505. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €632,835 excl. VAT; Tenders received: 5; Lot LOT-0146.
506. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €632,835 excl. VAT; Tenders received: 5; Lot LOT-0146.
507. 8 July 2026: Award. Winner: ETHYPHARM GmbH; Award value: €268,296 excl. VAT; Tenders received: 1; Lot LOT-0147.
508. 8 July 2026: Award. Winner: ETHYPHARM GmbH; Award value: €268,296 excl. VAT; Tenders received: 1; Lot LOT-0147.
509. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,651,900 excl. VAT; Tenders received: 4; Lot LOT-0148.
510. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,651,900 excl. VAT; Tenders received: 4; Lot LOT-0148.
511. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,651,900 excl. VAT; Tenders received: 4; Lot LOT-0148.
512. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,651,900 excl. VAT; Tenders received: 4; Lot LOT-0148.
513. 8 July 2026: Award. Winner: Nordmark Pharma GmbH; Award value: €4,128,382 excl. VAT; Tenders received: 2; Lot LOT-0149.
514. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €4,128,382 excl. VAT; Tenders received: 2; Lot LOT-0149.
515. 8 July 2026: Award. Winner: Nordmark Pharma GmbH; Award value: €4,128,382 excl. VAT; Tenders received: 2; Lot LOT-0149.
516. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €4,128,382 excl. VAT; Tenders received: 2; Lot LOT-0149.
517. 8 July 2026: Award. Winner: Grünenthal GmbH; Award value: €249,070 excl. VAT; Tenders received: 2; Lot LOT-0150.
518. 8 July 2026: Award. Winner: Grünenthal GmbH; Award value: €249,070 excl. VAT; Tenders received: 2; Lot LOT-0150.
519. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €151,549 excl. VAT; Tenders received: 3; Lot LOT-0151.
520. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €151,549 excl. VAT; Tenders received: 3; Lot LOT-0151.
521. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €151,549 excl. VAT; Tenders received: 3; Lot LOT-0151.
522. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €151,549 excl. VAT; Tenders received: 3; Lot LOT-0151.
523. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH) BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €4,150,194 excl. VAT; Tenders received: 6; Lot LOT-0152.
524. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €4,150,194 excl. VAT; Tenders received: 6; Lot LOT-0152.
525. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH) BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €4,150,194 excl. VAT; Tenders received: 6; Lot LOT-0152.
526. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €4,150,194 excl. VAT; Tenders received: 6; Lot LOT-0152.
527. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,867,997 excl. VAT; Tenders received: 7; Lot LOT-0154.
528. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,867,997 excl. VAT; Tenders received: 7; Lot LOT-0154.
529. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €1,867,997 excl. VAT; Tenders received: 7; Lot LOT-0154.
530. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,867,997 excl. VAT; Tenders received: 7; Lot LOT-0154.
531. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,867,997 excl. VAT; Tenders received: 7; Lot LOT-0154.
532. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €1,867,997 excl. VAT; Tenders received: 7; Lot LOT-0154.
533. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €720,240 excl. VAT; Tenders received: 7; Lot LOT-0155.
534. 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €720,240 excl. VAT; Tenders received: 7; Lot LOT-0155.
535. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €720,240 excl. VAT; Tenders received: 7; Lot LOT-0155.
536. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €720,240 excl. VAT; Tenders received: 7; Lot LOT-0155.
537. 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €720,240 excl. VAT; Tenders received: 7; Lot LOT-0155.
538. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €720,240 excl. VAT; Tenders received: 7; Lot LOT-0155.
539. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,845,574 excl. VAT; Tenders received: 5; Lot LOT-0156.
540. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,845,574 excl. VAT; Tenders received: 5; Lot LOT-0156.
541. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,845,574 excl. VAT; Tenders received: 5; Lot LOT-0156.
542. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,845,574 excl. VAT; Tenders received: 5; Lot LOT-0156.
543. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,845,574 excl. VAT; Tenders received: 5; Lot LOT-0156.
544. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,845,574 excl. VAT; Tenders received: 5; Lot LOT-0156.
545. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €2,210,072 excl. VAT; Tenders received: 11; Lot LOT-0157.
546. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,210,072 excl. VAT; Tenders received: 11; Lot LOT-0157.
547. 8 July 2026: Award. Winner: G.L. Pharma GmbH vertreten durch G.L. Pharma Deutschland GmbH; Award value: €2,210,072 excl. VAT; Tenders received: 11; Lot LOT-0157.
548. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €2,210,072 excl. VAT; Tenders received: 11; Lot LOT-0157.
549. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,210,072 excl. VAT; Tenders received: 11; Lot LOT-0157.
550. 8 July 2026: Award. Winner: G.L. Pharma GmbH vertreten durch G.L. Pharma Deutschland GmbH; Award value: €2,210,072 excl. VAT; Tenders received: 11; Lot LOT-0157.
551. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €3,225,518 excl. VAT; Tenders received: 6; Lot LOT-0158.
552. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,225,518 excl. VAT; Tenders received: 6; Lot LOT-0158.
553. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €3,225,518 excl. VAT; Tenders received: 6; Lot LOT-0158.
554. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,225,518 excl. VAT; Tenders received: 6; Lot LOT-0158.
555. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €6,996,120 excl. VAT; Tenders received: 12; Lot LOT-0159.
556. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €6,996,120 excl. VAT; Tenders received: 12; Lot LOT-0159.
557. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €6,996,120 excl. VAT; Tenders received: 12; Lot LOT-0159.
558. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €6,996,120 excl. VAT; Tenders received: 12; Lot LOT-0159.
559. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €6,996,120 excl. VAT; Tenders received: 12; Lot LOT-0159.
560. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €6,996,120 excl. VAT; Tenders received: 12; Lot LOT-0159.
561. 8 July 2026: Award. Winner: Sun Pharmaceuticals Germany GmbH; Award value: €492,749 excl. VAT; Tenders received: 2; Lot LOT-0160.
562. 8 July 2026: Award. Winner: Sun Pharmaceuticals Germany GmbH; Award value: €492,749 excl. VAT; Tenders received: 2; Lot LOT-0160.
563. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €124,833 excl. VAT; Tenders received: 2; Lot LOT-0161.
564. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €124,833 excl. VAT; Tenders received: 2; Lot LOT-0161.
565. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €678,198 excl. VAT; Tenders received: 5; Lot LOT-0162.
566. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €678,198 excl. VAT; Tenders received: 5; Lot LOT-0162.
567. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €678,198 excl. VAT; Tenders received: 5; Lot LOT-0162.
568. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €678,198 excl. VAT; Tenders received: 5; Lot LOT-0162.
569. 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €734,047 excl. VAT; Tenders received: 1; Lot LOT-0163.
570. 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €734,047 excl. VAT; Tenders received: 1; Lot LOT-0163.
571. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €338,879 excl. VAT; Tenders received: 2; Lot LOT-0164.
572. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €338,879 excl. VAT; Tenders received: 2; Lot LOT-0164.
573. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €821,472 excl. VAT; Tenders received: 2; Lot LOT-0165.
574. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €821,472 excl. VAT; Tenders received: 2; Lot LOT-0165.
575. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,511,318 excl. VAT; Tenders received: 9; Lot LOT-0166.
576. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,511,318 excl. VAT; Tenders received: 9; Lot LOT-0166.
577. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,511,318 excl. VAT; Tenders received: 9; Lot LOT-0166.
578. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,511,318 excl. VAT; Tenders received: 9; Lot LOT-0166.
579. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,039,128 excl. VAT; Tenders received: 6; Lot LOT-0167.
580. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €1,039,128 excl. VAT; Tenders received: 6; Lot LOT-0167.
581. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €1,039,128 excl. VAT; Tenders received: 6; Lot LOT-0167.
582. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,039,128 excl. VAT; Tenders received: 6; Lot LOT-0167.
583. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €1,039,128 excl. VAT; Tenders received: 6; Lot LOT-0167.
584. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €1,039,128 excl. VAT; Tenders received: 6; Lot LOT-0167.
585. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €810,767 excl. VAT; Tenders received: 8; Lot LOT-0168.
586. 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €810,767 excl. VAT; Tenders received: 8; Lot LOT-0168.
587. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €810,767 excl. VAT; Tenders received: 8; Lot LOT-0168.
588. 8 July 2026: Award. Winner: Vivanta Generics s.r.o.; Award value: €810,767 excl. VAT; Tenders received: 8; Lot LOT-0168.
589. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €178,302 excl. VAT; Tenders received: 2; Lot LOT-0169.
590. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €178,302 excl. VAT; Tenders received: 2; Lot LOT-0169.
591. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €178,302 excl. VAT; Tenders received: 2; Lot LOT-0169.
592. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €178,302 excl. VAT; Tenders received: 2; Lot LOT-0169.
593. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,097,973 excl. VAT; Tenders received: 3; Lot LOT-0170.
594. 8 July 2026: Award. Winner: Galenpharma GmbH; Award value: €1,097,973 excl. VAT; Tenders received: 3; Lot LOT-0170.
595. 8 July 2026: Award. Winner: mibe GmbH Arzneimittel; Award value: €1,097,973 excl. VAT; Tenders received: 3; Lot LOT-0170.
596. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,097,973 excl. VAT; Tenders received: 3; Lot LOT-0170.
597. 8 July 2026: Award. Winner: Galenpharma GmbH; Award value: €1,097,973 excl. VAT; Tenders received: 3; Lot LOT-0170.
598. 8 July 2026: Award. Winner: mibe GmbH Arzneimittel; Award value: €1,097,973 excl. VAT; Tenders received: 3; Lot LOT-0170.
599. 8 July 2026: Award. Winner: Ascend GmbH; Award value: €5,119,295 excl. VAT; Tenders received: 15; Lot LOT-0171.
600. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €5,119,295 excl. VAT; Tenders received: 15; Lot LOT-0171.
601. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €5,119,295 excl. VAT; Tenders received: 15; Lot LOT-0171.
602. 8 July 2026: Award. Winner: Ascend GmbH; Award value: €5,119,295 excl. VAT; Tenders received: 15; Lot LOT-0171.
603. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €5,119,295 excl. VAT; Tenders received: 15; Lot LOT-0171.
604. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €5,119,295 excl. VAT; Tenders received: 15; Lot LOT-0171.
605. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €58,138 excl. VAT; Tenders received: 6; Lot LOT-0172.
606. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €58,138 excl. VAT; Tenders received: 6; Lot LOT-0172.
607. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €143,243 excl. VAT; Tenders received: 1; Lot LOT-0174.
608. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €143,243 excl. VAT; Tenders received: 1; Lot LOT-0174.
609. 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €483,328 excl. VAT; Tenders received: 4; Lot LOT-0175.
610. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €483,328 excl. VAT; Tenders received: 4; Lot LOT-0175.
611. 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €483,328 excl. VAT; Tenders received: 4; Lot LOT-0175.
612. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €483,328 excl. VAT; Tenders received: 4; Lot LOT-0175.
613. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €430,301 excl. VAT; Tenders received: 1; Lot LOT-0176.
614. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €430,301 excl. VAT; Tenders received: 1; Lot LOT-0176.
615. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €110,282 excl. VAT; Tenders received: 2; Lot LOT-0177.
616. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €110,282 excl. VAT; Tenders received: 2; Lot LOT-0177.
617. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,028,562 excl. VAT; Tenders received: 7; Lot LOT-0178.
618. 8 July 2026: Award. Winner: Devatis GmbH; Award value: €2,028,562 excl. VAT; Tenders received: 7; Lot LOT-0178.
619. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €2,028,562 excl. VAT; Tenders received: 7; Lot LOT-0178.
620. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,028,562 excl. VAT; Tenders received: 7; Lot LOT-0178.
621. 8 July 2026: Award. Winner: Devatis GmbH; Award value: €2,028,562 excl. VAT; Tenders received: 7; Lot LOT-0178.
622. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €2,028,562 excl. VAT; Tenders received: 7; Lot LOT-0178.
623. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €599,172 excl. VAT; Tenders received: 1; Lot LOT-0179.
624. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €599,172 excl. VAT; Tenders received: 1; Lot LOT-0179.
625. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,364,230 excl. VAT; Tenders received: 4; Lot LOT-0181.
626. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,364,230 excl. VAT; Tenders received: 4; Lot LOT-0181.
627. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,364,230 excl. VAT; Tenders received: 4; Lot LOT-0181.
628. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,364,230 excl. VAT; Tenders received: 4; Lot LOT-0181.
629. 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €3,036,130 excl. VAT; Tenders received: 5; Lot LOT-0182.
630. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,036,130 excl. VAT; Tenders received: 5; Lot LOT-0182.
631. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,036,130 excl. VAT; Tenders received: 5; Lot LOT-0182.
632. 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €3,036,130 excl. VAT; Tenders received: 5; Lot LOT-0182.
633. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,036,130 excl. VAT; Tenders received: 5; Lot LOT-0182.
634. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €3,036,130 excl. VAT; Tenders received: 5; Lot LOT-0182.
635. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €200,985 excl. VAT; Tenders received: 8; Lot LOT-0183.
636. 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €200,985 excl. VAT; Tenders received: 8; Lot LOT-0183.
637. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €200,985 excl. VAT; Tenders received: 8; Lot LOT-0183.
638. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €200,985 excl. VAT; Tenders received: 8; Lot LOT-0183.
639. 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €200,985 excl. VAT; Tenders received: 8; Lot LOT-0183.
640. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €200,985 excl. VAT; Tenders received: 8; Lot LOT-0183.
641. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €62,403 excl. VAT; Tenders received: 2; Lot LOT-0184.
642. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €62,403 excl. VAT; Tenders received: 2; Lot LOT-0184.
643. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €62,403 excl. VAT; Tenders received: 2; Lot LOT-0184.
644. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €62,403 excl. VAT; Tenders received: 2; Lot LOT-0184.
645. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €595,421 excl. VAT; Tenders received: 6; Lot LOT-0185.
646. 8 July 2026: Award. Winner: Dexcel Pharma GmbH; Award value: €595,421 excl. VAT; Tenders received: 6; Lot LOT-0185.
647. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €595,421 excl. VAT; Tenders received: 6; Lot LOT-0185.
648. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €595,421 excl. VAT; Tenders received: 6; Lot LOT-0185.
649. 8 July 2026: Award. Winner: Dexcel Pharma GmbH; Award value: €595,421 excl. VAT; Tenders received: 6; Lot LOT-0185.
650. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €595,421 excl. VAT; Tenders received: 6; Lot LOT-0185.
651. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €34,505 excl. VAT; Tenders received: 3; Lot LOT-0186.
652. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €34,505 excl. VAT; Tenders received: 3; Lot LOT-0186.
653. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €435,668 excl. VAT; Tenders received: 3; Lot LOT-0187.
654. 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €435,668 excl. VAT; Tenders received: 3; Lot LOT-0187.
655. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €435,668 excl. VAT; Tenders received: 3; Lot LOT-0187.
656. 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €435,668 excl. VAT; Tenders received: 3; Lot LOT-0187.
657. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €880,509 excl. VAT; Tenders received: 6; Lot LOT-0188.
658. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €880,509 excl. VAT; Tenders received: 6; Lot LOT-0188.
659. 8 July 2026: Award. Winner: Luye Pharma AG; Award value: €880,509 excl. VAT; Tenders received: 6; Lot LOT-0188.
660. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €880,509 excl. VAT; Tenders received: 6; Lot LOT-0188.
661. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €880,509 excl. VAT; Tenders received: 6; Lot LOT-0188.
662. 8 July 2026: Award. Winner: Luye Pharma AG; Award value: €880,509 excl. VAT; Tenders received: 6; Lot LOT-0188.
663. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €296,232 excl. VAT; Tenders received: 4; Lot LOT-0189.
664. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €296,232 excl. VAT; Tenders received: 4; Lot LOT-0189.
665. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €296,232 excl. VAT; Tenders received: 4; Lot LOT-0189.
666. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €296,232 excl. VAT; Tenders received: 4; Lot LOT-0189.
667. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €137,311 excl. VAT; Tenders received: 4; Lot LOT-0190.
668. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €137,311 excl. VAT; Tenders received: 4; Lot LOT-0190.
669. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €137,311 excl. VAT; Tenders received: 4; Lot LOT-0190.
670. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €137,311 excl. VAT; Tenders received: 4; Lot LOT-0190.
671. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €320,471 excl. VAT; Tenders received: 2; Lot LOT-0191.
672. 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €320,471 excl. VAT; Tenders received: 2; Lot LOT-0191.
673. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €320,471 excl. VAT; Tenders received: 2; Lot LOT-0191.
674. 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €320,471 excl. VAT; Tenders received: 2; Lot LOT-0191.
675. 8 July 2026: Award. Winner: Adamed Pharma S.A. vertreten durch BERLIN-CHEMIE Aktiengesellschaft; Award value: €2,991,042 excl. VAT; Tenders received: 5; Lot LOT-0192.
676. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,991,042 excl. VAT; Tenders received: 5; Lot LOT-0192.
677. 8 July 2026: Award. Winner: Adamed Pharma S.A. vertreten durch BERLIN-CHEMIE Aktiengesellschaft; Award value: €2,991,042 excl. VAT; Tenders received: 5; Lot LOT-0192.
678. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,991,042 excl. VAT; Tenders received: 5; Lot LOT-0192.
679. 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €3,070,443 excl. VAT; Tenders received: 12; Lot LOT-0193.
680. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,070,443 excl. VAT; Tenders received: 12; Lot LOT-0193.
681. 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €3,070,443 excl. VAT; Tenders received: 12; Lot LOT-0193.
682. 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €3,070,443 excl. VAT; Tenders received: 12; Lot LOT-0193.
683. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,070,443 excl. VAT; Tenders received: 12; Lot LOT-0193.
684. 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €3,070,443 excl. VAT; Tenders received: 12; Lot LOT-0193.
685. 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €165,748 excl. VAT; Tenders received: 2; Lot LOT-0194.
686. 8 July 2026: Award. Winner: Bluefish Pharma GmbH; Award value: €165,748 excl. VAT; Tenders received: 2; Lot LOT-0194.
687. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,286,901 excl. VAT; Tenders received: 6; Lot LOT-0195.
688. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,286,901 excl. VAT; Tenders received: 6; Lot LOT-0195.
689. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €2,286,901 excl. VAT; Tenders received: 6; Lot LOT-0195.
690. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,286,901 excl. VAT; Tenders received: 6; Lot LOT-0195.
691. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €2,286,901 excl. VAT; Tenders received: 6; Lot LOT-0195.
692. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €2,286,901 excl. VAT; Tenders received: 6; Lot LOT-0195.
693. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €82,968 excl. VAT; Tenders received: 2; Lot LOT-0196.
694. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €82,968 excl. VAT; Tenders received: 2; Lot LOT-0196.
695. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,826,458 excl. VAT; Tenders received: 6; Lot LOT-0197.
696. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,826,458 excl. VAT; Tenders received: 6; Lot LOT-0197.
697. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,826,458 excl. VAT; Tenders received: 6; Lot LOT-0197.
698. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,826,458 excl. VAT; Tenders received: 6; Lot LOT-0197.
699. 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €2,970,173 excl. VAT; Tenders received: 14; Lot LOT-0198.
700. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €2,970,173 excl. VAT; Tenders received: 14; Lot LOT-0198.
701. 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €2,970,173 excl. VAT; Tenders received: 14; Lot LOT-0198.
702. 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €2,970,173 excl. VAT; Tenders received: 14; Lot LOT-0198.
703. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €2,970,173 excl. VAT; Tenders received: 14; Lot LOT-0198.
704. 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €2,970,173 excl. VAT; Tenders received: 14; Lot LOT-0198.
705. 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €1,867,063 excl. VAT; Tenders received: 17; Lot LOT-0199.
706. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €1,867,063 excl. VAT; Tenders received: 17; Lot LOT-0199.
707. 8 July 2026: Award. Winner: 089Pharm GmbH; Award value: €1,867,063 excl. VAT; Tenders received: 17; Lot LOT-0199.
708. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €1,867,063 excl. VAT; Tenders received: 17; Lot LOT-0199.
709. 8 July 2026: Award. Winner: Ascend GmbH; Award value: €440,164 excl. VAT; Tenders received: 12; Lot LOT-0200.
710. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €440,164 excl. VAT; Tenders received: 12; Lot LOT-0200.
711. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €440,164 excl. VAT; Tenders received: 12; Lot LOT-0200.
712. 8 July 2026: Award. Winner: Ascend GmbH; Award value: €440,164 excl. VAT; Tenders received: 12; Lot LOT-0200.
713. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €440,164 excl. VAT; Tenders received: 12; Lot LOT-0200.
714. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €440,164 excl. VAT; Tenders received: 12; Lot LOT-0200.
715. 8 July 2026: Award. Winner: Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH; Award value: €1,390,691 excl. VAT; Tenders received: 3; Lot LOT-0201.
716. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,390,691 excl. VAT; Tenders received: 3; Lot LOT-0201.
717. 8 July 2026: Award. Winner: Accord Healthcare B.V. vertreten durch Accord Healthcare GmbH; Award value: €1,390,691 excl. VAT; Tenders received: 3; Lot LOT-0201.
718. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,390,691 excl. VAT; Tenders received: 3; Lot LOT-0201.
719. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €211,582 excl. VAT; Tenders received: 1; Lot LOT-0202.
720. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €211,582 excl. VAT; Tenders received: 1; Lot LOT-0202.
721. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €683,621 excl. VAT; Tenders received: 7; Lot LOT-0203.
722. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €683,621 excl. VAT; Tenders received: 7; Lot LOT-0203.
723. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €683,621 excl. VAT; Tenders received: 7; Lot LOT-0203.
724. 8 July 2026: Award. Winner: betapharm Arzneimittel GmbH; Award value: €683,621 excl. VAT; Tenders received: 7; Lot LOT-0203.
725. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €683,621 excl. VAT; Tenders received: 7; Lot LOT-0203.
726. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €683,621 excl. VAT; Tenders received: 7; Lot LOT-0203.
727. 8 July 2026: Award. Winner: Dermapharm AG; Award value: €602,452 excl. VAT; Tenders received: 1; Lot LOT-0204.
728. 8 July 2026: Award. Winner: Dermapharm AG; Award value: €602,452 excl. VAT; Tenders received: 1; Lot LOT-0204.
729. 8 July 2026: Award. Winner: Abdi Farma GmbH; Award value: €190,879 excl. VAT; Tenders received: 7; Lot LOT-0205.
730. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €190,879 excl. VAT; Tenders received: 7; Lot LOT-0205.
731. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €190,879 excl. VAT; Tenders received: 7; Lot LOT-0205.
732. 8 July 2026: Award. Winner: Abdi Farma GmbH; Award value: €190,879 excl. VAT; Tenders received: 7; Lot LOT-0205.
733. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €190,879 excl. VAT; Tenders received: 7; Lot LOT-0205.
734. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €190,879 excl. VAT; Tenders received: 7; Lot LOT-0205.
735. 8 July 2026: Award. Winner: Abdi Farma GmbH; Award value: €958,035 excl. VAT; Tenders received: 8; Lot LOT-0206.
736. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €958,035 excl. VAT; Tenders received: 8; Lot LOT-0206.
737. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €958,035 excl. VAT; Tenders received: 8; Lot LOT-0206.
738. 8 July 2026: Award. Winner: Abdi Farma GmbH; Award value: €958,035 excl. VAT; Tenders received: 8; Lot LOT-0206.
739. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €958,035 excl. VAT; Tenders received: 8; Lot LOT-0206.
740. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €958,035 excl. VAT; Tenders received: 8; Lot LOT-0206.
741. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,630,126 excl. VAT; Tenders received: 10; Lot LOT-0207.
742. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,630,126 excl. VAT; Tenders received: 10; Lot LOT-0207.
743. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,630,126 excl. VAT; Tenders received: 10; Lot LOT-0207.
744. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €1,630,126 excl. VAT; Tenders received: 10; Lot LOT-0207.
745. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €740,191 excl. VAT; Tenders received: 5; Lot LOT-0208.
746. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €740,191 excl. VAT; Tenders received: 5; Lot LOT-0208.
747. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €113,901 excl. VAT; Tenders received: 2; Lot LOT-0209.
748. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €113,901 excl. VAT; Tenders received: 2; Lot LOT-0209.
749. 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €275,970 excl. VAT; Tenders received: 5; Lot LOT-0210.
750. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €275,970 excl. VAT; Tenders received: 5; Lot LOT-0210.
751. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €275,970 excl. VAT; Tenders received: 5; Lot LOT-0210.
752. 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €275,970 excl. VAT; Tenders received: 5; Lot LOT-0210.
753. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €275,970 excl. VAT; Tenders received: 5; Lot LOT-0210.
754. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €275,970 excl. VAT; Tenders received: 5; Lot LOT-0210.
755. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €542,090 excl. VAT; Tenders received: 8; Lot LOT-0211.
756. 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €542,090 excl. VAT; Tenders received: 8; Lot LOT-0211.
757. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €542,090 excl. VAT; Tenders received: 8; Lot LOT-0211.
758. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €542,090 excl. VAT; Tenders received: 8; Lot LOT-0211.
759. 8 July 2026: Award. Winner: Medical Valley Invest AB; Award value: €542,090 excl. VAT; Tenders received: 8; Lot LOT-0211.
760. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €542,090 excl. VAT; Tenders received: 8; Lot LOT-0211.
761. 8 July 2026: Award. Winner: Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH; Award value: €1,555,527 excl. VAT; Tenders received: 5; Lot LOT-0212.
762. 8 July 2026: Award. Winner: Devatis GmbH; Award value: €1,555,527 excl. VAT; Tenders received: 5; Lot LOT-0212.
763. 8 July 2026: Award. Winner: Medac Gesellschaft für klinische Spezialpräparate m.b.H.; Award value: €1,555,527 excl. VAT; Tenders received: 5; Lot LOT-0212.
764. 8 July 2026: Award. Winner: Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH; Award value: €1,555,527 excl. VAT; Tenders received: 5; Lot LOT-0212.
765. 8 July 2026: Award. Winner: Devatis GmbH; Award value: €1,555,527 excl. VAT; Tenders received: 5; Lot LOT-0212.
766. 8 July 2026: Award. Winner: Medac Gesellschaft für klinische Spezialpräparate m.b.H.; Award value: €1,555,527 excl. VAT; Tenders received: 5; Lot LOT-0212.
767. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €615,386 excl. VAT; Tenders received: 8; Lot LOT-0213.
768. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €615,386 excl. VAT; Tenders received: 8; Lot LOT-0213.
769. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €615,386 excl. VAT; Tenders received: 8; Lot LOT-0213.
770. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €615,386 excl. VAT; Tenders received: 8; Lot LOT-0213.
771. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €568,583 excl. VAT; Tenders received: 6; Lot LOT-0214.
772. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €568,583 excl. VAT; Tenders received: 6; Lot LOT-0214.
773. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €568,583 excl. VAT; Tenders received: 6; Lot LOT-0214.
774. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €568,583 excl. VAT; Tenders received: 6; Lot LOT-0214.
775. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €477,632 excl. VAT; Tenders received: 13; Lot LOT-0215.
776. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €477,632 excl. VAT; Tenders received: 13; Lot LOT-0215.
777. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €477,632 excl. VAT; Tenders received: 13; Lot LOT-0215.
778. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €477,632 excl. VAT; Tenders received: 13; Lot LOT-0215.
779. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €477,632 excl. VAT; Tenders received: 13; Lot LOT-0215.
780. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €477,632 excl. VAT; Tenders received: 13; Lot LOT-0215.
781. 8 July 2026: Award. Winner: Besins Healthcare Germany GmbH; Award value: €180,092 excl. VAT; Tenders received: 1; Lot LOT-0216.
782. 8 July 2026: Award. Winner: Besins Healthcare Germany GmbH; Award value: €180,092 excl. VAT; Tenders received: 1; Lot LOT-0216.
783. 8 July 2026: Award. Winner: Galenpharma GmbH; Award value: €1,509,826 excl. VAT; Tenders received: 5; Lot LOT-0217.
784. 8 July 2026: Award. Winner: mibe GmbH Arzneimittel; Award value: €1,509,826 excl. VAT; Tenders received: 5; Lot LOT-0217.
785. 8 July 2026: Award. Winner: Galenpharma GmbH; Award value: €1,509,826 excl. VAT; Tenders received: 5; Lot LOT-0217.
786. 8 July 2026: Award. Winner: mibe GmbH Arzneimittel; Award value: €1,509,826 excl. VAT; Tenders received: 5; Lot LOT-0217.
787. 8 July 2026: Award. Winner: Aristo Pharma GmbH; Award value: €146,321 excl. VAT; Tenders received: 2; Lot LOT-0218.
788. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €146,321 excl. VAT; Tenders received: 2; Lot LOT-0218.
789. 8 July 2026: Award. Winner: Aristo Pharma GmbH; Award value: €146,321 excl. VAT; Tenders received: 2; Lot LOT-0218.
790. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €146,321 excl. VAT; Tenders received: 2; Lot LOT-0218.
791. 8 July 2026: Award. Winner: Aristo Pharma GmbH; Award value: €99,755 excl. VAT; Tenders received: 2; Lot LOT-0219.
792. 8 July 2026: Award. Winner: Aristo Pharma GmbH; Award value: €99,755 excl. VAT; Tenders received: 2; Lot LOT-0219.
793. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €296,946 excl. VAT; Tenders received: 3; Lot LOT-0220.
794. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €296,946 excl. VAT; Tenders received: 3; Lot LOT-0220.
795. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,055,436 excl. VAT; Tenders received: 4; Lot LOT-0221.
796. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,055,436 excl. VAT; Tenders received: 4; Lot LOT-0221.
797. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €1,055,436 excl. VAT; Tenders received: 4; Lot LOT-0221.
798. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,055,436 excl. VAT; Tenders received: 4; Lot LOT-0221.
799. 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €707,327 excl. VAT; Tenders received: 4; Lot LOT-0222.
800. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €707,327 excl. VAT; Tenders received: 4; Lot LOT-0222.
801. 8 July 2026: Award. Winner: axunio Pharma GmbH; Award value: €707,327 excl. VAT; Tenders received: 4; Lot LOT-0222.
802. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €707,327 excl. VAT; Tenders received: 4; Lot LOT-0222.
803. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €151,468 excl. VAT; Tenders received: 1; Lot LOT-0223.
804. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €151,468 excl. VAT; Tenders received: 1; Lot LOT-0223.
805. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €183,567 excl. VAT; Tenders received: 1; Lot LOT-0224.
806. 8 July 2026: Award. Winner: Micro Labs GmbH; Award value: €183,567 excl. VAT; Tenders received: 1; Lot LOT-0224.
807. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €124,471 excl. VAT; Tenders received: 2; Lot LOT-0225.
808. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €124,471 excl. VAT; Tenders received: 2; Lot LOT-0225.
809. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €205,975 excl. VAT; Tenders received: 2; Lot LOT-0226.
810. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €205,975 excl. VAT; Tenders received: 2; Lot LOT-0226.
811. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €205,975 excl. VAT; Tenders received: 2; Lot LOT-0226.
812. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €205,975 excl. VAT; Tenders received: 2; Lot LOT-0226.
813. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,552,713 excl. VAT; Tenders received: 1; Lot LOT-0227.
814. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €1,552,713 excl. VAT; Tenders received: 1; Lot LOT-0227.
815. 8 July 2026: Award. Winner: Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH; Award value: €2,113,932 excl. VAT; Tenders received: 3; Lot LOT-0228.
816. 8 July 2026: Award. Winner: Ascend GmbH; Award value: €2,113,932 excl. VAT; Tenders received: 3; Lot LOT-0228.
817. 8 July 2026: Award. Winner: Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH; Award value: €2,113,932 excl. VAT; Tenders received: 3; Lot LOT-0228.
818. 8 July 2026: Award. Winner: Ascend GmbH; Award value: €2,113,932 excl. VAT; Tenders received: 3; Lot LOT-0228.
819. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €3,629,564 excl. VAT; Tenders received: 3; Lot LOT-0229.
820. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,629,564 excl. VAT; Tenders received: 3; Lot LOT-0229.
821. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €3,629,564 excl. VAT; Tenders received: 3; Lot LOT-0229.
822. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €3,629,564 excl. VAT; Tenders received: 3; Lot LOT-0229.
823. 8 July 2026: Award. Winner: Libra-Pharm GmbH; Award value: €55,302 excl. VAT; Tenders received: 2; Lot LOT-0230.
824. 8 July 2026: Award. Winner: Libra-Pharm GmbH; Award value: €55,302 excl. VAT; Tenders received: 2; Lot LOT-0230.
825. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €170,478 excl. VAT; Tenders received: 3; Lot LOT-0231.
826. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €170,478 excl. VAT; Tenders received: 3; Lot LOT-0231.
827. 8 July 2026: Award. Winner: Libra-Pharm GmbH; Award value: €170,478 excl. VAT; Tenders received: 3; Lot LOT-0231.
828. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €170,478 excl. VAT; Tenders received: 3; Lot LOT-0231.
829. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €170,478 excl. VAT; Tenders received: 3; Lot LOT-0231.
830. 8 July 2026: Award. Winner: Libra-Pharm GmbH; Award value: €170,478 excl. VAT; Tenders received: 3; Lot LOT-0231.
831. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €901,208 excl. VAT; Tenders received: 4; Lot LOT-0232.
832. 8 July 2026: Award. Winner: Libra-Pharm GmbH; Award value: €901,208 excl. VAT; Tenders received: 4; Lot LOT-0232.
833. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €901,208 excl. VAT; Tenders received: 4; Lot LOT-0232.
834. 8 July 2026: Award. Winner: Libra-Pharm GmbH; Award value: €901,208 excl. VAT; Tenders received: 4; Lot LOT-0232.
835. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €67,850 excl. VAT; Tenders received: 2; Lot LOT-0233.
836. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €67,850 excl. VAT; Tenders received: 2; Lot LOT-0233.
837. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €96,291 excl. VAT; Tenders received: 1; Lot LOT-0234.
838. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €96,291 excl. VAT; Tenders received: 1; Lot LOT-0234.
839. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €492,818 excl. VAT; Tenders received: 3; Lot LOT-0235.
840. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €492,818 excl. VAT; Tenders received: 3; Lot LOT-0235.
841. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €492,818 excl. VAT; Tenders received: 3; Lot LOT-0235.
842. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €492,818 excl. VAT; Tenders received: 3; Lot LOT-0235.
843. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,709,665 excl. VAT; Tenders received: 1; Lot LOT-0238.
844. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,709,665 excl. VAT; Tenders received: 1; Lot LOT-0238.
845. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €65,567 excl. VAT; Tenders received: 2; Lot LOT-0239.
846. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €65,567 excl. VAT; Tenders received: 2; Lot LOT-0239.
847. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €463,249 excl. VAT; Tenders received: 7; Lot LOT-0240.
848. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €463,249 excl. VAT; Tenders received: 7; Lot LOT-0240.
849. 8 July 2026: Award. Winner: Amarox Pharma GmbH; Award value: €463,249 excl. VAT; Tenders received: 7; Lot LOT-0240.
850. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €463,249 excl. VAT; Tenders received: 7; Lot LOT-0240.
851. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €232,954 excl. VAT; Tenders received: 1; Lot LOT-0241.
852. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €232,954 excl. VAT; Tenders received: 1; Lot LOT-0241.
853. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,693,403 excl. VAT; Tenders received: 8; Lot LOT-0242.
854. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,693,403 excl. VAT; Tenders received: 8; Lot LOT-0242.
855. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,693,403 excl. VAT; Tenders received: 8; Lot LOT-0242.
856. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,693,403 excl. VAT; Tenders received: 8; Lot LOT-0242.
857. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,693,403 excl. VAT; Tenders received: 8; Lot LOT-0242.
858. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €1,693,403 excl. VAT; Tenders received: 8; Lot LOT-0242.
859. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft)BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €815,592 excl. VAT; Tenders received: 6; Lot LOT-0243.
860. 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €815,592 excl. VAT; Tenders received: 6; Lot LOT-0243.
861. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €815,592 excl. VAT; Tenders received: 6; Lot LOT-0243.
862. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft)BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €815,592 excl. VAT; Tenders received: 6; Lot LOT-0243.
863. 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €815,592 excl. VAT; Tenders received: 6; Lot LOT-0243.
864. 8 July 2026: Award. Winner: Zentiva Pharma GmbH; Award value: €815,592 excl. VAT; Tenders received: 6; Lot LOT-0243.
865. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,677,567 excl. VAT; Tenders received: 6; Lot LOT-0244.
866. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,677,567 excl. VAT; Tenders received: 6; Lot LOT-0244.
867. 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €1,677,567 excl. VAT; Tenders received: 6; Lot LOT-0244.
868. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €1,677,567 excl. VAT; Tenders received: 6; Lot LOT-0244.
869. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,677,567 excl. VAT; Tenders received: 6; Lot LOT-0244.
870. 8 July 2026: Award. Winner: TAD Pharma GmbH; Award value: €1,677,567 excl. VAT; Tenders received: 6; Lot LOT-0244.
871. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,648,563 excl. VAT; Tenders received: 6; Lot LOT-0245.
872. 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €1,648,563 excl. VAT; Tenders received: 6; Lot LOT-0245.
873. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €1,648,563 excl. VAT; Tenders received: 6; Lot LOT-0245.
874. 8 July 2026: Award. Winner: Macleods Pharma Espana S.L.U.; Award value: €1,648,563 excl. VAT; Tenders received: 6; Lot LOT-0245.
875. 8 July 2026: Award. Winner: AAA-Pharma GmbH; Award value: €2,033,334 excl. VAT; Tenders received: 6; Lot LOT-0246.
876. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €2,033,334 excl. VAT; Tenders received: 6; Lot LOT-0246.
877. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,033,334 excl. VAT; Tenders received: 6; Lot LOT-0246.
878. 8 July 2026: Award. Winner: AAA-Pharma GmbH; Award value: €2,033,334 excl. VAT; Tenders received: 6; Lot LOT-0246.
879. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €2,033,334 excl. VAT; Tenders received: 6; Lot LOT-0246.
880. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €2,033,334 excl. VAT; Tenders received: 6; Lot LOT-0246.
881. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €130,251 excl. VAT; Tenders received: 3; Lot LOT-0247.
882. 8 July 2026: Award. Winner: Dexcel Pharma GmbH; Award value: €130,251 excl. VAT; Tenders received: 3; Lot LOT-0247.
883. 8 July 2026: Award. Winner: BG Heumann / Heunet GbR (Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH); Award value: €130,251 excl. VAT; Tenders received: 3; Lot LOT-0247.
884. 8 July 2026: Award. Winner: Dexcel Pharma GmbH; Award value: €130,251 excl. VAT; Tenders received: 3; Lot LOT-0247.
885. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €120,872 excl. VAT; Tenders received: 3; Lot LOT-0248.
886. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €120,872 excl. VAT; Tenders received: 3; Lot LOT-0248.
887. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €120,872 excl. VAT; Tenders received: 3; Lot LOT-0248.
888. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €120,872 excl. VAT; Tenders received: 3; Lot LOT-0248.
889. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €227,918 excl. VAT; Tenders received: 1; Lot LOT-0249.
890. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €227,918 excl. VAT; Tenders received: 1; Lot LOT-0249.
891. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €191,721 excl. VAT; Tenders received: 2; Lot LOT-0250.
892. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €191,721 excl. VAT; Tenders received: 2; Lot LOT-0250.
893. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €61,023 excl. VAT; Tenders received: 2; Lot LOT-0251.
894. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €61,023 excl. VAT; Tenders received: 2; Lot LOT-0251.
895. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €192,504 excl. VAT; Tenders received: 1; Lot LOT-0252.
896. 8 July 2026: Award. Winner: BG ALIUD / STADAPHARM GbR (ALIUD PHARMA GmbH, STADAPHARM GmbH); Award value: €192,504 excl. VAT; Tenders received: 1; Lot LOT-0252.
897. 8 July 2026: Award. Winner: Denk Pharma GmbH & Co. KG; Award value: €195,844 excl. VAT; Tenders received: 2; Lot LOT-0253.
898. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €195,844 excl. VAT; Tenders received: 2; Lot LOT-0253.
899. 8 July 2026: Award. Winner: Denk Pharma GmbH & Co. KG; Award value: €195,844 excl. VAT; Tenders received: 2; Lot LOT-0253.
900. 8 July 2026: Award. Winner: Viatris Healthcare GmbH; Award value: €195,844 excl. VAT; Tenders received: 2; Lot LOT-0253.
901. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €121,433 excl. VAT; Tenders received: 3; Lot LOT-0254.
902. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €121,433 excl. VAT; Tenders received: 3; Lot LOT-0254.
903. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €121,433 excl. VAT; Tenders received: 3; Lot LOT-0254.
904. 8 July 2026: Award. Winner: neuraxpharm Arzneimittel GmbH; Award value: €121,433 excl. VAT; Tenders received: 3; Lot LOT-0254.
905. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €150,324 excl. VAT; Tenders received: 4; Lot LOT-0255.
906. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €150,324 excl. VAT; Tenders received: 4; Lot LOT-0255.
907. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €150,324 excl. VAT; Tenders received: 4; Lot LOT-0255.
908. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €150,324 excl. VAT; Tenders received: 4; Lot LOT-0255.
909. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €435,063 excl. VAT; Tenders received: 6; Lot LOT-0256.
910. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €435,063 excl. VAT; Tenders received: 6; Lot LOT-0256.
911. 8 July 2026: Award. Winner: Glenmark Arzneimittel GmbH; Award value: €435,063 excl. VAT; Tenders received: 6; Lot LOT-0256.
912. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €435,063 excl. VAT; Tenders received: 6; Lot LOT-0256.
913. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €422,086 excl. VAT; Tenders received: 5; Lot LOT-0257.
914. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €422,086 excl. VAT; Tenders received: 5; Lot LOT-0257.
915. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €422,086 excl. VAT; Tenders received: 5; Lot LOT-0257.
916. 8 July 2026: Award. Winner: BG Hexal 1 A Pharma GbR (1 A Pharma GmbH, H e x a l Aktiengesellschaft); Award value: €422,086 excl. VAT; Tenders received: 5; Lot LOT-0257.
917. 8 July 2026: Award. Winner: BG TEVA ratiopharm GbR (AbZ-Pharma GmbH, ratiopharm GmbH, TEVA GmbH); Award value: €422,086 excl. VAT; Tenders received: 5; Lot LOT-0257.
918. 8 July 2026: Award. Winner: PUREN Pharma GmbH & Co. KG; Award value: €422,086 excl. VAT; Tenders received: 5; Lot LOT-0257.
919. 27 July 2026, 15:42 (UTC+02:00): Award notice Notice, version 01 (Contract or concession award notice – standard regime). Official notice
920. 29 July 2026, 16:25 (UTC+02:00): Award notice Notice, version 01 (Contract or concession award notice – standard regime). Official notice

Buyer and place

Classification

Official documents

No documents found in the indexed notice.

Questions and answers

More from this buyer

Other published opportunities of this buyer in the indexed notices, open ones first.

• OpenTender

  Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren

  Buyer

  IKK classic

  Place

  DED21 (Sachsen)

  Deadline

  5 Sept 2028, 23:59 (UTC+02:00)

  CPV

  33600000

  Last checked 7 Nov 2026, 14:30 (UTC+01:00)Official notice
• OpenTender

  Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren

  Buyer

  IKK classic

  Place

  DED21 (Sachsen)

  Deadline

  5 Jul 2028, 23:59 (UTC+02:00)

  CPV

  33600000

  Last checked 8 Nov 2026, 11:30 (UTC+01:00)Official notice
• AwardedTender

  Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der Besins Healthcare Germany GmbH zu Testogel

  Buyer

  IKK classic

  Deadline

  No deadline in the notice

  Published value

  €1 excl. VAT

  CPV

  33600000

  Last checked 6 Nov 2026, 07:11 (UTC+01:00)Official notice
• AwardedTender

  Abschluss eines nicht-exklusiven Rabattvertrages gemäߧ 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx

  Buyer

  IKK classic

  Place

  DED21 (Sachsen)

  Deadline

  No deadline in the notice

  CPV

  33600000

  Last checked 4 Nov 2026, 12:10 (UTC+01:00)Official notice
• AwardedTender

  Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der G.L. Pharma Deutschland GmbH zu Remosan

  Buyer

  IKK classic

  Deadline

  No deadline in the notice

  Published value

  €1 excl. VAT

  CPV

  33600000

  Last checked 7 Nov 2026, 13:30 (UTC+01:00)Official notice

Related opportunities

• OpenTender

  Lieferung und Montage von drei OP-Tischsystemen inkl. erforderlichen Zubehörs

  Buyer

  Evangelisches Klinikum Westerwald gGmbH

  Place

  DEB18 (Rheinland-Pfalz)

  Deadline

  No deadline in the notice

  CPV

  33100000, 33192230

  Last checked 9 Nov 2026, 20:30 (UTC+01:00)Official notice
• OpenTender

  Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Trientin (ATC-Code nach WHO: A16AX12)

  Buyer

  AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen

  Place

  DED21 (Sachsen)

  Deadline

  30 Sept 2028, 23:58 (UTC+02:00)

  CPV

  33600000

  Last checked 9 Nov 2026, 20:30 (UTC+01:00)Official notice
• OpenTender

  EEG - System mit Service- u. Wartungsvertrag über 5 Jahre

  Buyer

  Universitätsklinikum Aachen AöR

  Place

  DEA2D (Nordrhein-Westfalen)

  Deadline

  No deadline in the notice

  CPV

  33121100, 50420000

  Last checked 9 Nov 2026, 18:30 (UTC+01:00)Official notice
• OpenTender

  Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Epinephrin (ATC-Code nach WHO: C01CA24) in der Darreichung Nasenspray

  Buyer

  AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen

  Place

  DED21 (Sachsen)

  Deadline

  30 Sept 2027, 23:58 (UTC+02:00)

  CPV

  33600000

  Last checked 9 Nov 2026, 16:30 (UTC+01:00)Official notice
• OpenTender

  Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu biosimilaren Wirkstoffen

  Buyer

  GWQ ServicePlus AG

  Place

  DEA11 (Nordrhein-Westfalen)

  Deadline

  10 Aug 2027, 10:00 (UTC+02:00)

  CPV

  33600000

  Last checked 9 Nov 2026, 16:30 (UTC+01:00)Official notice
• OpenTender

  Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Epinephrin (ATC-Code nach WHO: C01CA24) in der Darr. Fertigspritze/-pen

  Buyer

  AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen

  Place

  DED21 (Sachsen)

  Deadline

  30 Sept 2027, 23:58 (UTC+02:00)

  CPV

  33600000

  Last checked 9 Nov 2026, 16:30 (UTC+01:00)Official notice

Source